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1 Executive Summary 
Our team spent one month performing observations in the Department of Obstetrics & 
Gynecology at Komfo Anokye Teaching Hospital (KATH), a main referral hospital located in 
Kumasi, Ghana. During this time, we observed a deficit in the supply of donor blood available at 
the blood bank. As a result, the hospital had developed a manual autologous transfusion method 
for use in ruptured ectopic pregnancies, which minimizes or eliminates the need for donor blood 
in these cases. This procedure requires many labor- and material-intensive steps and can cause 
further harm to the patient due to poor quality control of the blood. Therefore, our team 
identified the opportunity to create a blood salvage device that can be operated by a health care 
provider to collect, filter and transfuse blood in the event of severe blood loss that occurs during 
ruptured ectopic pregnancies and other hemoperitoneum hemorrhage procedures. 
After identifying this opportunity, we spent one week gathering user requirements and 
engineering specifications through a series of stakeholder interviews. Quantification into 
engineering specifications was completed through expert interviews and review of the literature. 
After multiple brainstorming sessions, we emerged with five distinct system designs. Following 
a rigorous analysis with use of a Pugh chart, weighting system based on the ability of the concept 
to meet the user requirements, and creation of pro and con lists, we chose the “giant syringe” as 
the alpha design.  
Our final design is the result of multiple iterations on the alpha design. The “giant syringe” is a 
self-contained, mechanically powered system composed essentially of a large-scale syringe with 
an internal filter. Three check valves direct flow of blood into the reservoir of the syringe and 
then subsequently into an attached blood bag through an outlet valve. An o-ring provides an air 
tight seal between the plunger and the reservoir housing, and a hollow, tapered tip provides 
storage for larger clots which are caught by a coarse internal filter before blood passes through 
an additional fine internal filter. Some of the benefits of the system include the lack of an 
expensive pump and the ease of maintenance due to a small number of parts and a simple design. 
However, the design also requires very high tolerances in manufacturing in order to create the 
necessary vacuum pressure to draw blood into the reservoir and is prone to clogging from blood 
clots. 
Following the manufacturing and assembly of the prototype, we were able to conduct initial 
functional and human factors validation testing. Functional testing revealed mean flow rates of 
1.6±1.0 L/min and 2.0±0.8 L/min for novice and experienced users, respectively, without any 
formal training. Additionally, the device was shown to be capable of processing 2L of liquid, can 
be operated by a single user, and requires less than 30 minutes of training time. Additionally, 
because the device is disposable, it would be presented to users fully assembled, so the only steps 
involved in readying it for use would be to connect it to the blood bag. 
 
Human factors testing revealed that while users were comfortable with the overall function of the 
device, there is room to improve in the design. Specifically, further analysis and redesign of the 
handle is recommended, as well as the addition of a grip or handle of some sort on the reservoir 





Our team spent one month performing observations in Komfo Anokye Teaching Hospital 
(KATH), a main referral hospital in Kumasi, Ghana. During this time, we observed a deficit in 
the available blood supply at the blood bank, as a result of which a manual autologous 
transfusion method was used in cases of ruptured ectopic pregnancies. We identified an 
opportunity for the development of a blood salvage device that can be operated by a health care 
provider to collect blood from a hemorrhaging patient (as occurs during ruptured ectopic 
pregnancy), filter it, and transfuse it back into the patient. We hope to help address the issue of 
minimal donated blood and reduce the likelihood of infections and other complications that 
could occur due to current blood salvaging procedures. 
3 Problem Definition  
3.1 Ethnographic Research 
This past August a multi-disciplinary group of students from the University of Michigan traveled 
to Kumasi, Ghana as the first cohort in the College of Engineering’s Global Heath Design 
Specialization. This group of students performed in-depth observations, brainstorming, and 
interviews in efforts to partner with the committed medical staff at Komfo Anokye Teaching 
Hospital (KATH). During this time, it was observed that a major challenge for the hospital was 
that of a blood bank with a severely limited blood supply. The worldwide total deficit of blood 
units available for transfusion was 40 million units per year in 2008. In addition, Africa has the 
lowest quantity of blood donated for transfusion per person in the world (Bates, 2008).    
Ectopic pregnancy ruptures occur daily at KATH in part due to various barriers that prevent 
early detection by doctors in the antenatal clinic, which is similar to many situations throughout 
Africa and specifically within Ghana. Even in the developed world, ectopic pregnancy can be 
difficult to detect because 50% of patients are asymptomatic before rupture occurs (Tulandi, 
2010). The rupture itself is caused by the implantation of the pregnancy outside of the uterus, 
usually in the fallopian tube, and leads to 300-1000 mL of blood loss contained within the 
abdominal cavity. In many cases, this blood can be salvaged and transfused back into the patient 
in what can often be a life-threatening procedure (Priuli, 2009). Ruptured ectopic pregnancy has 
recorded case-fatality rates of 1-3% in developing countries, which is ten times higher than the 
rates recorded in developed countries (Mignini, 2007).  
Figure 1: Ruptured Ectopic Pregnancy (Laparoscopic 
management of ectopic pregnancy) 
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Currently, the hospital implements a very labor- and material-intensive blood salvage method 
during certain surgical procedures. The head of the OB/GYN department at KATH, Dr. A.T. 
Odoi, along with other medical staff and mentors such as Dr. Kofi Amoah and Kwame 
Akwaboah, helped us to understand the complications that arise from this procedure. These 
include various infections and the possibility of causing cancerous growths by transfusion 
placental tissue. These discussions focused on ectopic pregnancy rupture (Figure 1), which is the 
leading cause of maternal mortality in the first trimester of pregnancy (UN Millennium Project). 
3.2 Needs Statement  
Based on these observations, we identified that there is a need for a blood salvage device that can 
be operated by a health care provider to collect blood from a hemorrhaging patient, filter this 
blood and transfuse it back into the patient. This would help to address the lack of available 
donated blood and improve the prognosis for the patient. 
3.3 Scope of Application 
Within obstetrics and gynecology, the term hemorrhage is used to refer to several different types 
of situations; therefore, it is important to specifically identify the intended scope of our design. 
As shown in Figure 2 below, major obstetric hemorrhage cases can be roughly divided into 
postpartum and hemoperitoneum (blood in the abdominal cavity) hemorrhage. Hemoperitoneum 
hemorrhage can be further divided into contaminated and uncontaminated cases; contaminated 
refers to cases in which the blood has been mixed with other bodily substances, such as placental 
tissue or fecal matter. In contaminated cases, the impurities must be removed before the blood is 
re-transfused. We are, therefore, narrowing our focus to include only uncontaminated abdominal 
surgeries. In obstetrics, the most applicable instance of this is in ruptured ectopic pregnancies. 
This procedure will serve as a case study, allowing us to validate our design with close 
cooperation between our team and the medical staff at KATH. This device may also have the 
potential to address other obstetric and emergency hemoperitoneum and hemothorax procedures. 
The ultimate goal would be to expand the scope of the device to address the much more pressing 

























The current aim of this project is to develop a coarse prototype for field testing at KATH next 
February to confirm that the device has accurately addressed the end users’ needs. The current 
user requirements will have to be re-evaluated to address similar challenges in health care 
settings that are smaller and more rural than KATH, most particularly in district hospitals. 
KATH is unique in Ghana in that it is a major referral hospital with more extensive resources 
than most tertiary facilities. Rural hospitals will have a modified set of requirements due to 
additional limitations on energy and resources, but it is evident that the need for a device such as 
this is greatest in a rural setting, since these locations lack even the limited blood bank available 
at KATH. 
4 Information Sources 
4.1 Background on Autologous Blood Transfusion 
The general lack of blood for transfusion in developing countries has been well established by 
public health researchers and documented in academic literature.  Autologous transfusion, in 
which the patient’s own blood is collected, filtered, and returned to them, has been considered as 
one of the viable options to help alleviate the current shortage of donated blood. Autologous 
transfusion also eliminates many of the risks associated with allogenic blood transfusion (the 
transfusion of donor blood). Assuming no clerical errors, the risk of contracting diseases, 
including HIV/AIDS and Creutzfeldt-Jakob disease, among others, is completely removed. 
Additionally, crossmatching and iso-immunization to foreign proteins is unnecessary when using 
autologous blood (Adias, 2006). 
Clinical studies have been performed to compare allogenic and autologous transfusion during 
ruptured ectopic pregnancy repair surgeries. No difference in complications (postoperative fever, 
postoperative wound infection, or prolonged hospital stay) was observed between the two 
groups. Patients in the autologous group were 6 times more likely to receive more than 1000 
milliliters of blood and to have a higher postoperative hematocrit level than those in the allogenic 
group. The authors hypothesized that this was due to the fact that allogenic blood transfusions 
are given as sparingly as possible, resulting in patients receiving the minimum amount of blood 
necessary to survive (Selo-Ojeme D. O.-W., 2007). 
There are three main types of autologous blood transfusions performed in the clinical setting.  
Preoperative autologous donation (PAD) is used for planned surgeries with large expected blood 
losses.  Blood is collected from the patient several weeks before the surgery and transfused after 
hemorrhage has stopped during the surgery.  This method is very effective in reducing the need 
for allogenic blood and eliminates the risks of hemolytic, febrile or allergic reactions.  Time is an 
important factor in performing PAD, as sufficient time must be allowed for the patient to replace 
some of the lost blood prior to surgery. PAD is normally more expensive than allogenic 
transfusions due to the added costs of increased administrative management of the blood units 
(Adias, 2006; Silvergleid, Intraoperative and postoperative blood salvage, 2009) 
Acute normovolaemic hemodilution (ANH), also termed intraopertive hemodilution, is another 
preoperative autologous transfusion method, wherein blood is collected from the patient 
immediately before surgery and the lost volume replaced with a colloid or crystalloid. The 
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collected blood can be transfused back into the patient once the patient is hemostable. This 
serves to minimize the blood volume lost during the surgery.  The amount of blood that can be 
removed is limited and varies with the size of the patient. ANH cannot be used if the patient has 
already lost a large amount of blood, and is therefore not applicable in emergent situations 
involving heavy bleeding. Unlike PAD, ANH is more cost effective than allogenic transfusion.  
The main reasons for this are that the costs of testing, crossmatching and storing the blood are 
eliminated (Adias, 2006; Silvergleid, 2008). 
The final type of autologous transfusion is intraoperative blood salvage (IBS), which can also be 
termed intraopertive autologous transfusion. In this method, blood is collected during surgery, 
processed, and returned to the patient. Processing methods vary, and can involve simple filtration 
or centrifugation and washing. Simple filtration transfuses whole blood back into the patient, 
while centrifugation and washing transfuses only packed red blood cells. The main advantage of 
this method over the previous two is the capacity to provide large quantities of autologous blood 
very rapidly. As the vast majority of ruptured ectopic pregnancy surgeries are performed in 
emergent situations, intraoperative salvage is the most suitable type of autologous transfusion for 
these patients (Adias, 2006; Silvergleid, 2009). 
The addition of an anticoagulant is a vital step in all the methods of autologous transfusion.  
Adding an anticoagulant prevents new clots from forming in the collected blood, though it has no 
effect on existing clots. The most common anticoagulant used is citrate-phosphate-dextrose-
adenine (CPDA-1). This anticoagulant comes prepackaged in most blood transfusion kits, and 
can prolong the shelf life of the blood unit by several weeks (Forson, 2010). Other 
anticoagulants, such as heparin, can be used at the surgeon’s discretion. 
4.2 Associated Risks of Autologous Transfusion 
4.2.1 Hemolysis and Coagulopathy 
The main risks associated with autologous transfusion are coagulopathy (clotting disorders), 
hemolysis (rupture of red blood cells) and infection. Hemolysis can occur and cause subsequent 
coagulopathy if the blood is subjected to excess mechanical stress or if the blood is contaminated 
with bacteria. To avoid this, autologous transfusion should not exceed 4000 milliliters and 
should be done within four hours of removal (Ansaloni, 1996; Selo-Ojeme D. O.-W., 2007). 
Using the correct amount of anticoagulant can further reduce this risk. Coagulopathy can also 
occur due to the presence of thromboplastic substances (proteins necessary for clotting)   and 
other coagulation system components present in whole blood, which has led to the belief that 
transfusing whole blood is riskier than transfusing packed red blood cells (Silvergleid, 2009). 
However, interviews with expert physicians have indicated that transfusing whole blood is 
preferable in many cases due to the fact that whole blood contains many other substances 





Figure 3: Components of Whole Blood (Robinson, 2010) 
Further research in this area is needed to confirm which approach is most effective (Johnson, 
2010). Additionally, infections can occur if any part of the device is exposed to the environment. 
Prophylactic antibiotics are commonly used to prevent infection (Odoi, 2010). 
4.2.2 Air and Fat Embolisms 
Air embolisms (air bubbles entering the veins) as shown in Figure 4 can occur during any 
transfusion procedure (allogenic or autologous) if proper protocols are not followed or devices 
are misused. Severe air embolisms can be catastrophic for the patient and cause complications in 
any organ system. Modern autologous transfusion devices have in-line air detectors which are 
used to prevent air embolisms. Most blood transfusion kits also have a mechanism to prevent air 
from entering the bloodstream during transfusion. Any new device must account for air 
embolisms as a potential side effect when considering design variables. Fat embolisms, while 
less likely to occur than air embolisms, can also cause complications during transfusion. Fat 
embolisms can be prevented by removing microaggregates from the blood (Silvergleid, 2009). 
 
Figure 4: Embolism in an artery (Memory Loss & the Brain, 2010) 
4.2.3 Salvaged Blood Syndrome 
Salvaged blood syndrome has been reported primarily in cases of transfusing packed red blood 
cells, though the theoretical risk exists for whole blood as well. The mechanism for the 
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development of this syndrome is not well understood, but activation of platelets and white blood 
cells appears to be the cause. In this syndrome, the patient develops disseminated intravascular 
coagulation (DIC) and/or increased capillary permeability in the lungs (Silvergleid, 2009). DIC 
causes hemorrhage and thrombosis (blood clots), producing an array of complications that must 
be treated by transfusing platelets and clotting factors (Leung, 2009). Increased capillary 
permeability can cause pulmonary edema and shortness of breath. These symptoms are difficult 
to treat and often only treatment of the underlying disease will result in cessation of symptoms 
(Givertz, 2009).This syndrome can be prevented by using citrate as the anticoagulant as well as 
avoiding aspirating blood that has been heavily diluted by surgical fluids (Silvergleid, 
Intraoperative and postoperative blood salvage, 2009). 
4.2.4 Hypotension 
The rare but serious risk of severe hypotension has been reported in isolated cases. When 
receiving autologous blood, some patients have experienced a life-threatening drop in blood 
pressure that returned to safe levels only when the transfusion was halted. No antibodies or other 
abnormal features were found in the blood that could have been responsible for the drop in blood 
pressure. This phenomenon remains unexplained, through it is hypothesized that the bedside 
leukocyte filter used during many autologous transfusions passes the blood through a pressurized 
tube, which could result in the excretion of vasodilating agents. The FDA reported in 1999 that 
severe hypotensive events occur in approximately 80 out of 20 million (0.004%) transfusion 
cases (Kessack, 2010). 
4.3 Maternal Mortality and MDG5 
In 2000, the UN created the Millenium Development Goals (MDGs), which provide a 
framework to tackle the many issues contributing to extreme poverty around the world. MDG 5 
is focused on improving maternal health, with specific targets of reducing the maternal mortality 
ratio between 1990 and 2015 by 75% and achieving universal access to reproductive health care 
by 2015 (UN Millennium Project). According to The Millennium Development Goals Report 
produced by the UN in 2010, as of 2008 only 46% of births in sub-Saharan Africa included a 
trained health care attendant (compared to 99% of births in developed regions of the world, and 
an average of 63% in the developing regions) (The Millenium Development Goals Report, 
2010). Of the 350,000 women who die every year from complications during pregnancy or 
childbirth, 99% of these deaths occur in the developing world, and most are preventable (UN 
Millennium Project). 
Currently, progress on MDG5 is lagging behind the schedule needed to achieve a 75% reduction 
in maternal mortality. At the UN Summit in late September 2010, Secretary-General Ban Ki-
moon announced the creation of a “Global Strategy for Women’s and Children’s Health,” part of 
a massive effort to improve performance in the area of MDG5, including the commitment of $40 
billion from various governments, private corporations, and UN agencies, among other groups, 
to achieve results on MDG5 (Deen, 2010). 
4.4 Current Autotransfusion Technology 
Intraoperative blood salvage first became widely used in the mid-1970s with the introduction of 
two different systems: the centrifuge-based cell salvage system and the passive canister 
collection system. A centrifuge-based cell salvage system was first marketed by Haemonetics in 
1974. The company’s “Cell Saver” brand has become so widely accepted that centrifuge-based 
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cell salvage systems are commonly referred to as cell savers. Sorin, Fesenius Kabi, Davol, 
Medtronic, and many other companies produce their own versions of a cell-saver. These devices 
are widely used throughout the United States, Western Europe, and other developed nations 
(Haemonetics: products and programs - Cell Saver 5 system; Silvergleid, Intraoperative and 
postoperative blood salvage, 2009). 
4.4.1 Cell Saver 
Cell saver devices are used in a variety of different surgeries, but all operate in a similar manner. 
The Haemonetics Cell Saver 5 is shown, as an example, in Figure 5. First, the surgeon aspirates 
blood with a suction wand. The wand is attached to a double-channel of tubing, which allows an 
anticoagulant to be mixed with the blood as it passes through the channel. The blood is collected 
in a reservoir until the volume reaches a level that is large enough to process (a minimum of 70 
mL), and is then pumped into a centrifuge bowl. The centrifuge separates the blood components 
into layers, and the layer of concentrated red blood cells is saved and washed in saline. 
Typically, the hematocrit level of this suspension is greater than 50%. The washed red blood 
cells are then transferred to an infusion bag and connected to the patient via an IV drip 
(Haemonetics: products and programs - Cell Saver 5 system).  
 
Figure 5: Haemonetics Cell Saver 5 (Haemonetics: products and programs - Cell Saver 5 system) 
Current cell savers are extremely efficient, capable of washing 225 milliliters of blood in about 
three minutes, the equivalent of 12 units of blood per hour. The major limitation of these devices 
is cost, as cell savers retail for over $30,000 (Silvergleid, Intraoperative and postoperative blood 
salvage, 2009). The complex components of these devices also present a challenge to the hospital 
maintenance departments of developing countries, which are ill-prepared to service these 
machines. 
4.4.2 Boehringer Autovac 
Very few autotransfusion devices are currently available that transfuse whole blood products. 
Boehringer Laboratories manufactures an autologous blood transfusion system called Autovacc 
(Figure 6) that has the potential to be used in developing countries. The cost of blood collection 
with this device can be less than half the cost of using a cell saver. The system transfuses whole 
blood back into the patient, costs $200, and can be attached to a standard vacuum aspirator. 
While this device shows promise in addressing blood salvage in a cost-efficient manner, it 
requires a separate vacuum aspirator and has a maximum capacity of only 1 L of blood 




Figure 6: Boehringer Autovac (Boehringer Labs, 2009) 
4.4.3 EAT-SET 
The Emergency Auto Transfusion Set (EAT-SET) device was developed in Nigeria by Brigadier 
General Dr. Ovadje to address the issue of blood shortages in developing countries. EAT-SET is 
a simple device consisting of a hand pump, filters, a single reservoir, tubing, and a blood bag 
(Figure 7). The hand pump is used to create a vacuum, removing blood from a hemorrhaging 
patient, which then passes through a gravity driven filter and into a blood bag. The hand pump 
can also be replaced by a vacuum aspirator in places where electricity is not reliably available. 
The device is designed for use in emergency autotransfusion cases with severe internal bleeding 
(EAT-SET). EAT-SET appears to address the need we had identified (although without a 
technical data sheet we have no way of determining if it meets all of our user requirements and 
engineering specifications); however, our team was unable to find any U.S. patent for the device, 
and the most recent reference was dated 2006. Additionally, Dr. Odoi was unaware of the 
existence of the device. We therefore concluded that it had stalled in the implementation stage. 
 
 
Figure 7: EAT-SET device with hand pump (EAT-SET) 
4.4.4 Funnel/Soup Ladle Autotransfusion 
Most surgeons in developing countries currently use a variation of the “soup ladle” method of 
autologous transfusion specifically for ruptured ectopic pregnancies.  This procedure generally 
begins with a laparotomy, which gives the surgeon access to the abdominal cavity. The largest 
visible clots are removed by hand, and the remaining blood is scooped out using a soup ladle, 
large spoon, or cup held with forceps. This blood is poured over a nurse’s hands to perform 
initial filtering of large clots, and is then collected in a bowl. An anticoagulant is added, and the 
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blood is transferred into a pitcher through a funnel lined with several layers of sterile gauze. It is 
then poured into a blood bag and connected to the patient via an IV drip (Ansaloni, 1996). 
This method is problematic for several reasons. First, excessive handling of the blood and 
exposure to the environment results in a high risk of contamination and subsequent infection. All 
patients receiving this type of transfusion must be given prophylactic antibiotics to stave off 
potential infections. Secondly, filtering through gauze does not remove all clots and other 
particulates, and small threads of the gauze can be mixed in with the blood. This increases the 
risk of coagulopathy, as well as the potential for an adverse immune response (Odoi, 2010). 
Finally, this method is labor-intensive, requiring a scrub nurse to filter the blood. Most 
developing countries have severe human resource shortages, especially in the area of health care, 
and eliminating the need for additional staff would be very advantageous (Chen, 2004).  
5 User Requirements and Engineering Specifications 
5.1 Process to Obtain User Requirements 
The project requirements were determined during the course of the month-long observations at 
KATH. Interviews were conducted with doctors, nurses, and technicians.  Based on the results of 
these interviews, we developed a preliminary list of user requirements.  We then distributed 
surveys (Appendix 21.13) to these same personnel asking them to rank the user requirements.  
With the 17 returned surveys, it was possible to rank the user requirements in order of 
descending importance. 
5.2 Ranking System 
The survey responders were asked to rank the identified user requirements by their perceived 
importance: a rank of 1 was the highest priority, a rank of 3 was medium priority, and a rank of 9 
was lowest priority. These rankings were then summed, with the lowest numbers representing 
the most important requirements. Due to a limited number of responses, we were unable to 
weight the results in a way that would provide both significant and accurate results, and therefore 
used a straight average of stakeholder responses. 
One common problem we encountered was the tendency of users to rank every requirement as 
“high priority.” To circumvent this issue, we also asked them to choose the five most important 
and five least important requirements. In summing the survey results, a point was deducted from 
a requirement’s total for each “most important” ranking, and a point was added for each “least 
important” ranking. The results are a clearly delineated ranking system, shown in Table 1. 
Table 1: Ranked user requirements 
User Requirement Raw Score 
Removes particulates and blood clots 7 
Minimizes contamination from environment 14 
Minimizes risk of cross contamination between patients 17 
Can be used in any clean abdominal surgery 20 
Prevents air embolisms 24 
Device is low maintenance 27 
Alerts user when malfunctioning 27 
Durable and long lasting 28 
Easy to operate by any staff in surgical setting 29 
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Device is low cost 31 
Connects to existing blood transfusion kit 32 
Can contain large amounts of blood loss 33 
Measures amount transfused to patient 35 
Quick transition to backup power 36 
Main power source is electrical 43 
Device can be operated quickly 43 
Device is portable 48 
Device is small 50 
Can change transfusion rate 50 
Measures amount of blood lost by patient 52 
Backup power source is mechanical 56 
Device is quiet 57 
5.3 Translating to Engineering Specifications 
These user requirements were then translated into engineering specifications, either through 
direct literature research or through interviews which were then verified with the literature 
whenever possible.  Table 2 below shows a modified list of user requirements matched to 
engineering specifications. The preliminary user requirement list was modified based on new 
findings from literature research and subsequent interviews with various stakeholders. The exact 
process for obtaining each engineering specification is described in Section 5.4. 
One major problem we encountered was the implicit assumption that the device would function 
appropriately. Because this user requirement was not explicitly stated outside of requirements 
such as “removes particulates and blood clots” and “can contain large amounts of blood loss,” 
this idea was not adequately represented in the user requirements listed on the survey. To address 
this, we added several user requirements based on literature research. Additionally, after further 
conversations with a number of clinicians, including both Dr. Odoi and Dr. Johnson, we 
reworded and reordered several of the existing user requirements. The current list of user 
requirements reflects our team’s efforts to accurately represent the needs expressed by our end 
users (Johnson, 2010; Odoi, 2010). We are in contact with a number of clinicians in Ghana, who 
have reviewed the results of our first two design reviews. Because of logistical challenges, we 
have been unable to have an in-depth conversation with Dr. Odoi, but through email contact, he 
and two other health care providers have confirmed that our list of user requirements (as of 
Design Review 2) is satisfactory. 
Our current engineering specifications are shown in Table 2 below. The double line in the table 
separates critical requirements from those which are considered non-critical, based primarily on 
the results of the customer survey distributed in Ghana, as well as additional literature research. 
All of the requirements above the line must be addressed; those below the line. The items below 
the line are those our team considers optional (based on results of the initial survey); ideally, they 
will be included if possible, but since it is unlikely that we will be able to design a device which 






Table 2: Sorted user requirements and engineering specifications 





Removes particulate matter ≥ 170 µm in diameter Filtering efficiency of 98% 





Closed system 0 openings to environment 
Noticeable if device malfunctions Force on plunger >45 N 
Durable Withstand drop from 2 m 





Flow rate removes blood sufficiently ≥ 0.5 L/min 
Measures total blood collected ≤ ±10 mL accuracy 
Easy to operate 
Training time < 30 min 
1 operator required 
< 5 steps for operation 
Force applied ≤ 48 N 
Diameter of grip ≤ 3 in. 
 Low cost $10-15 
 
Compatible with or replaces blood transfusion kit ≥ 20 drops/min infusion rate 
≤ 450 mL blood bag volume 
Compatible with 3mm tubing on blood 
bag 
 Quick to operate Set-up time of < 2 min 
Time to first transfusion is ≤ 10 min 
 Small and portable ≤ 15.5 kg filled 
 Quiet Operating level ≤ 50 dB 
5.4 Detailed Specifications 
 
Removes particulate matter: This requirement was consistently ranked one of the most 
important by all the clinicians and staff surveyed. Anecdotal interviews suggested that clots can 
be seen as large as 20 cm in diameter (Forson, 2010). Further research indicated that clots and 
particulates must be filtered to a level of 170 µm to reach a satisfactory risk level for transfusion. 
The standard level of efficiency for filters of any pore size is 98% (Hankins, 2001). 
 
Does not damage blood cells: Our initial literature research indicated that a vacuum pressure 
greater than 150mmHg would result in increased cellular destruction of the whole blood, making 
the transfusion process ineffective or potentially harmful for the patient. Therefore, a maximum 
vacuum pressure of 150 mmHg is indicated as our engineering specification (Radl, 2010). 
Additionally, all of the materials the blood comes in contact with must be biocompatible. 
 
Closed system: To ensure patient safety, contamination of blood from the surrounding 
environment should be minimal. To this end, Dr. Odoi expressed that he would like to minimize 
health care providers’ physical contact with the blood by developing a closed system which 
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would transport the blood from the patient, through a filtration system, and either into a blood 
bag or directly to the patient for transfusion (Odoi, 2010). 
 
Noticeable if device malfunctions: An alert of some kind to notify the surgical staff if the 
device was malfunctioning was requested by a senior resident (Larbi, 2010). He stated that the 
volume of a cell phone ring tone should be loud enough to get the attention of the surgeon. In 
additional interviews, technicians added that the frequency of an auditory device should not 
exceed 15 kHz (Akwaboah, 2010). However, more recent interviews with Dr. Odoi suggested 
that an alert should not be restricted to an auditory mechanism. Therefore, the specification was 
changed to indicate the point at which a clinician should be notified that the device is 
malfunctioning (Odoi, 2010). 
 
Since moving to a purely mechanical, disposable system, this specification had to be redefined. 
Because the operator is using their own mechanical power to operate the device, they should be 
able to determine if the device is becoming more difficult to operate because of clogging. This 
was anecdotally proven during functional validation testing. The value of 45 N was measured as 
the maximum force (with error) needed to operate the device with no clogging present. 
 
Durable: The durability of the device is best described as its ability to withstand the impact 
force of being dropped from a certain height, since that is the most probable method of damaging 
a handheld device. Two meters was chosen as that height because it is representative of the 
average height of an adult man. 
 
Can manage significant blood loss: According to senior clinicians at both KATH and the 
University of Michigan Health System, the maximum blood loss that a patient can sustain before 
imminent death is 2 L (Amoah, 2010). Anecdotal evidence from literature indicates a maximum 
blood loss from ruptured ectopic pregnancies of 2500 mL (Hall, 1979). The device should be 
able to remove 2-2.5 L of blood without becoming clogged. 
 
Flow rate removes blood sufficiently: In interviews, clinicians indicated that the flow rate of 
the current suction machine in use at KATH was ideal, and they would like to see a comparable 
flow rate on any similar machine (Adagebe, 2010; Quarshie, 2010). That flow rate was estimated 
at 3.5-6 L/min, based on benchmarking comparisons with similar suction machines (Atmos 
Record 55). However, in additional conversations with Dr. Frank Anderson, he stressed that the 
blood must be removed within 5 minutes of opening the patient’s abdomen so that the surgeon 
can begin repairing the hemorrhage. With a maximum blood loss of 2-3 L, this results in a much 
lower minimum acceptable flow rate, in the range of 0.5 L/min (Anderson, 2010).  
 
Measures total blood collected: It is important for the physician to be able to estimate both the 
amount of blood that the patient has lost and the amount that has been transfused in order to 
determine the proper course of treatment. Dr. Odoi has indicated that an accuracy of ±10 mL in 
measuring this value would be acceptable (Odoi, 2010). 
 
Easy to operate: There is a serious human resource shortage in sub-Saharan Africa, especially 
in the area of skilled health workers (Chen, 2004). Therefore, this device should be designed 
such that anyone in the operating theater can use it with minimal training. Limited personnel are 
19 
 
available and only one person is required to operate the suction machine currently in use; 
therefore, the number of personnel needed should be minimal. Benchmarking with the current 
suction machine yielded a maximum 5-step set-up process. A maximum training time of 30 
minutes was recommended by a senior clinician, and confirmed in the observation of training 
time designated for new equipment which arrived during our observation period (Konney, 2010). 
Additionally, the female 5th percentile force that can be applied in a position needed to operate 
our device is 48 N, so we set the maximum force to this value so that most users will be able to 
operate the device. 
 
Low cost: Our original cost values of $350-700 for an initial investment and $2-4 per procedure 
were suggested by a clinician (Konney, 2010).  However, these values were assuming the device 
was electrical in nature (much like the current suction machine) and reflect a much higher cost 
than is appropriate for a disposable device.  We have attempted to look into benchmark costs of 
other disposable devices with little success.  Dr. Johnson provided us with a disposable syringe-
type device designed to evacuate the uterus for miscarriges.  The device is designed for use in 
resource-limited settings, but we have been unable to find its cost despite several attempts to 
contact the distributing company. 
 
We have sought to discuss issues of cost with several clinicians, including Dr. Odoi and Dr. 
Kibitala, who visited recently. We have been unable to get any ranges from them that make 
sense. Thus, we have had to estimate our ideal cost, at least for the time being. We do know that 
currently, patients at KATH are charged 18.50 GHS for blood transfusions, which corresponds to 
approximately $12.90.  We would like to be in this range of costs for a disposable device, around 
$10-15.    
 
Any discussion of cost should also include a mention of reimbursement by the national Ghanaian 
insurance plan, since it was anecdotally reported that the majority of patients are enrolled in the 
insurance plan. Additionally, the issue of cost is vital when considering scaling of this design, 
since cost is an important prohibitive factor in the purchase of any new technology, especially in 
limited-resource settings.  
 
Compatible with or replaces current blood transfusion kit: The current blood transfusion kit 
has two ports on it that could be used as transfer points in the bag.  The device will use standard 
tubing that can be attached to either port. Multiple doctors asked that this requirement be met; 
since the staff is already familiar with the use of the current transfusion kit, this would also serve 
to make the device easier to use (Odoi, 2010). 
 
Quick to operate: The requirement that the device be quick to operate can be defined in 
multiple ways. We were able to quantify this concept in terms of the time needed to set up the 
machine (< 2 minutes) and the time between the first use of the machine on the patient and the 
availability of blood for transfusion (< 2-3 minutes). These values were the result of clinician 
interviews (Adagebe, 2010). Further research into transfusion protocol in trauma situations 
indicated that the fastest possible time to transfuse blood in emergencies in U.S. hospitals was in 
the range of 10-15 minutes (Legacy Health System, 2004). The time to reach hemostasis can be 
up to 18-29 minutes without adverse effects for the patient (Takeda, 2006). The time to first 




Small and portable: With the change to a handheld design, the main limitation for this 
requirement is the total weight. Anthropometric data showed a 10th percentile female isometric 
arm lifting strength of 22.8 lbs or 10.3 kg (Batti'e, 1989). This should be the maximum weight of 
the device when it is filled with blood. Blood has a density of 1.06 g/mL, and we plan to have a 
reservoir with a maximum volume of ~500 mL, so the maximum weight of the remaining 
materials is 10 kg. Additionally, the device should be small enough that it can be operated by 
anyone; the primary limiting factor is the diameter of the reservoir. We set the maximum 
diameter of 2.5 in. to fit the 5th percentile female hand size of 6.4 in (Woodson, 1992). 
 
Quiet: In discussions of operating volume, hospital staff indicated that the operating volume of 
the current suction machine was acceptable. The benchmarking procedure described previously 
found an operating volume of similar machines to be in the range of 50 dB. 
 
5.5 QFD 
In addition to the procedure described above for obtaining user requirements and engineering 
specifications, our team also developed a QFD diagram to further examine the relationships and 
interactions between various engineering requirements and user specifications. The primary 
conflict revealed during this process was that between patient safety and cost efficiency. 
Additionally, while completing the QFD diagram, several gaps in our engineering specifications 
became apparent. The two most important of these were in quantifying a measure of 
contamination and a clear definition of specifications regarding a backup power source.  
6 Concept Generation 
Our first step in concept generation was to create a functional decomposition diagram (Appendix 
21.4) breaking up the tasks the device was required to perform. The categories that we included 
were precursory removal of large clots; insertion of the device into the open abdominal cavity; 
withdrawal of blood from the cavity; transportation to a container (reservoir); removal of clots, 
particulates, and microaggregates; prevention of new clots; and transportation of blood back into 
the body. These steps must also occur in the order outlined above, with the exception that the 
blood not necessarily be filtered before it is transported to a reservoir, but it must be filtered 
before it is transfused. We also created a category purely to analyze suction methods, since that 
was the basis of movement of blood throughout our system. We then held several in-depth 
brainstorming sessions, in which we generated concepts for each functional component as a 
group (Appendix 21.5). We also performed individual brainstorming for each component. 
A Pugh chart was then created to compare the concepts we had generated for each functional 
component (Appendix 21.6). In terms of collecting blood, we concluded that suction or a siphon 
would be the top choice, which would be paired with a scoop wand including a screen or a dual 
chamber tube for clots and blood. We later discarded the siphon technique when the group 
realized the flow would stop if the device was not fully submerged in the blood, which would 
make it extremely difficult for the surgeon to use. The systems that were created to clean the 
blood were composed of a gravity-powered filter, a “salad spinner” technique, or a funnel with 
groves. All of these would connect to a storage reservoir, from which individual blood bags 
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would be filled and hung from the IV stand for transfusion, as is done in all current procedures. 
We also determined that silicon could be used within the device to help prevent the formation of 
new clots. The final issue was the decision of where or whether to inject additional 
anticoagulant, which is already present in the current blood bag. 
A systems brainstorming session was performed with our class discussion section in order to 
discover the best way to integrate the components we had generated thus far in the selection 
process, and also helped identify new components we had overlooked. 
7 Concept Selection 
In evaluating ideas generated within our group and by the class, we developed five complete 
systems. We chose the system that integrated the most highly ranked components, was most 
feasible within the scope of our engineering skills, and most fully addressed our user 
requirements by making a pros and cons list for each design (Appendix 21.7). 
The initially chosen concept was designated as the “Salad Spinner” design (Figure 9), in which 
the filter is spinning in a chamber. The chamber contains multiple filters, with the larger pore 
sizes in the center and the smaller in the outside of the chamber. In this way the filter with the 
smallest pore size has the largest surface area, which should reduce clogging of the system. 
Tubes would be connected to the inlet of the filtering chamber to the patient, and from the outlet 
to a reservoir from which a blood bag is filled. We also hypothesized that the centripetal force 
created from the spinning filter could potentially create a pressure differential large enough to 
withdraw the blood from the body. However, if this force is not strong enough, a pump would 
need to be added. Some possible setbacks that would need to be addressed in the design are the 











A more complicated concept was the “Dual Action Pump (Figure 9).” This design was composed 
of many separate components that scored well in the component-based Pugh chart. A pump is 
connected to two reservoirs. The first is located before the filtration system and collects 
unfiltered blood from the body. The second is located after the filtration system and collects 
Figure 9: Dual action pump design Figure 8: Salad spinner design 
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filtered blood which is then drained into blood bags for transfusion. The filtration system would 
be a simple gravity filter, helped along by the suction created by the pump through the second 
reservoir. In this way, the pump serves to both collect blood from the body and force it through 
the filtration system. The system also includes a series of valves, which would isolate the 
different components for greater control over individual flow rates. The complicated design 
includes many parts, which would most likely result in high manufacturing cost and increased 
maintenance. This fact alone limits the feasibility in our targeted setting.  
 
In order to address the requirement generated at KATH that the device be electrically powered, 
while still attempting to create something that could be applicable to rural settings with unstable 
or non-existent electrical grids, the team devised a modular system (Figure 10). This device 
would be composed of a stand-alone suction machine and a stand-alone filtering system. Where 
electricity is readily available and reliable, the suction machine and filter module could be used 
together, but in cases without electricity, the filter module could be used separately with gravity-
based filtration and a possible foot pump. The system would also directly fill standard blood bags 
with filtered blood to be hung on an IV stand. Major limitations of the design include the 
complexity, number of components, and high maintenance potential of the system. 
 
A concept closely resembling a “water bottle,” (Figure 11) was the idea that came very close to 
being chosen over the “salad spinner.” The main reservoir would be compressed by the user, 
creating a negative pressure when released which would draw blood through the filter at the tip 
and into the reservoir. A valve is placed on the bottom of the reservoir to allow blood to flow out 
and either into a second reservoir or directly into a blood bag. The concept was exceptional in 
that the filter was handheld (making it very portable), was manually powered, and could possibly 
be used in a wide scope of settings. This concept was not chosen because it was determined that 
it probably could not handle a large amount of blood loss at once, there was a high potential for 
backflow if more than one compression is required, and the device would have to be fully 
submerged within the blood (the primary reason the siphon method was excluded). In terms of 
sanitation, the “Water Bottle” concept would have to be a flexible material, which likely would 
not be autoclavable. 
 
Figure 10: Modular design 
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After initially choosing the “Salad Spinner” concept as our alpha design, the team generated a 
fifth distinctly different system concept, in which we attempted to create a simple, small, hand-
held concept, similar to the “Water Bottle” design. During brainstorming, we had initially 
overlooked simple system designs, instead focusing on generating components which could be 
combined into a whole system. This methodology resulted in very complex systems. While 
evaluating the pros and cons of each system, the simple “Giant Syringe” concept emerged. This 
is a self-contained, man-powered system with no expensive pump necessary, composed 
essentially of a large-scale syringe with an internal filter. Unlike the “Water Bottle” concept, the 













When analyzed against the user requirements and the Pugh chart, the concept made sense on 
almost all levels. The concerns that the team believes we can address in the future development 
of the prototype are the blood volume capacity, flow rate, and being prone to clogging. The 
energy required from the user to operate the device will also have to be a major point of focus 
when deciding whether to move forward with this concept. The device could feed directly into a 
blood bag, so the volume would not need to be larger than 450 mL, but would have to expand 
several times to collect all the blood in the cavity. The device could also be designed such that it 
would withdraw enough blood in one expansion to fill multiple blood bags, but that could result 
in it being rather heavy. A major concern was that the design might actually be too “low-tech” 
for our users at KATH, who are expecting a more complex, electrically powered solution. We 
have still been unable to hold a detailed interview with Dr. Odoi to receive his feedback on this 
design concept. However, in conversations with Dr. Johnson, he was very enthusiastic about this 
concept and confident that we were moving in the correct direction with this design. We will 
continue efforts to contact Dr. Odoi, but will move forward with this design based on Dr. 
Johnson’s feedback. 
Figure 12: Water bottle design Figure 11: Giant syringe design 
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8 Design Evolution 
Our team has completed multiple iterations of our chosen design (the giant syringe), outlined in 
Table 3. The primary functional mechanisms of the design have not changed significantly 
between iterations. Each design includes three major functional components: tip (A), syringe 
reservoir (B), and exit valve connected to a blood bag (C).  The device operates by first creating 
a negative pressure difference on the upward stroke of the plunger, which draws blood through 
the tip (A) and into the syringe reservoir (B). The plunger is then forced downwards (down 
stroke) and the blood is transferred into a blood bag through an outlet (C). This process is 
repeated in a continuous cycle until the blood intended for autotransfusion is completely 
evacuated from the patient’s abdomen. Later designs also include one or more check valves to 
prevent clean blood from flowing back through the filter and out the tip. 
Our initial design (alpha design) included a fine internal filter to remove clots and particulates 
≥170 μm in diameter. An exit valve which would be attached directly to a blood bag was 
positioned at the top of the main reservoir. The major problem with this design was the lack of a 
mechanism to prevent backflow of filtered blood through the filter and out the tip when the 
plunger was compressed. The position of the exit valve to the blood bag meant that the plunger 
would have to be fully withdrawn before blood could be evacuated from the device. There was 
no mechanism (such as a coarse filter) to remove larger clots before they reached the fine filter, 
which would likely result in faster clogging of the fine internal filter. The method for attaching 
the internal filter was not considered. Additionally, no human factors were accounted for in the 
design: the hand size and the reservoir diameter, or the force needed to draw back the plunger. 
Our beta design addresses some of these issues. The exit valve to the blood bag has been moved 
to the bottom of the reservoir, allowing greater freedom in evacuation of blood to the blood bag. 
A one-way valve has been added above the fine internal filter to prevent backflow of blood 
through the tip. The diameter of the reservoir has been changed to 2.5” to fit the 5th percentile 
female hand size. Several problems still remain. There is still no coarse filter to remove the 
largest clots, and attachment of the fine filter remains unclear. The plunger handle is optimized 
for ease of manufacturing rather than for the user’s comfort.  
The third design, the gamma design, has a coarse internal filter as well as the fine one. A 
chamber has been added so that a filter manufactured by a third party can be easily placed inside, 
and internal lips provide attachment for the coarse filter, most likely with some sort of glue. 
There are a total of three one-way valves, one on either side of the filters and one on the exit to 
the blood bag, which prevent backflow, protect the filter from force on the down stroke, and 
prevent clean blood from being drawn back up from the blood bag on the up stroke of the 
plunger. A rubber O-ring is placed on the plunger to maintain an airtight seal. The plunger 
handle was redesigned so that it would be easier for the user to create a substantial force when 
drawing the plunger back. The tip of the device was changed to a tapered design, which makes 
the manufacturing process easier (in attaching the tip to the main body of the device) and may 
provide greater field of vision for the user. 
Several problems remain with this design. The filters are still prone to clogging, but it is difficult 
to accurately predict the speed with which they might clog. Literature searches have yet to yield 
any definitive numbers on the size and quantity of clots found in cases of ectopic rupture. These 
factors depend primarily on the time between the initial rupture and onset of internal bleeding 
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and the start of the surgical repair (Takeda, 2006). The tapered tip, while easier to attach to the 
main reservoir, may need an extension piece to allow the surgeon to reach all areas of the 
abdomen where blood has pooled. Additionally, a cavity at the top of the tip piece is intended to 
store larger clots removed by the coarse filter. The number and size of clots is largely determined 
by the time between the initial rupture and the operation, and we have been unable to find 
information about either this time period or the rate of clotting. Anecdotal evidence suggests that 
ruptures can occur several hours before a patient is seen by a physician and that clots can be up 
to 20 cm in diameter.   
During this design process, we decided to alter our design from a reusable device with a few 
disposable parts to an entirely disposable device. This decision was made primarily due to the 
added complexity that a partially disposable design entailed. The one component which would be 
disposable in all situations is the filter. Therefore, the filter would have to be removed and 
replaced, requiring additional training and increasing the time to set up the device, as well as 
adding a step which increases the potential for contamination, since the filter would likely be 
exposed during this process. The complications in the manufacturing process were also 
significant, since the piece containing the internal filter would need to be removable. We 
considered placing the filter outside the main body of the device, in the tubing to the blood bag, 
but rejected this because of the added bulk, which would detract from one of the primary 
advantages of our design (it is small and portable). Finally, the supply of consumable parts is 
unreliable in resource-limited settings (Malkin, 2007). This would result in our device becoming 

















Table 3: Evolution of final design 
 Description Shortcomings 
Alpha Design 
 
• Fine internal filter removes 
smallest clots and particulates 
• Exit valve to blood bag keeps 
clean blood inside system 
• No coarse filter 
• Attachment of internal filter is 
unclear 
• Exit valve to blood bag is 
poorly positioned 
• No mechanism to prevent blood 
exiting from tip (backflow) 
• No human factors accounted for 




• Fine internal filter removes 
smallest clots and particulates 
• Exit valve to blood bag moved to 
bottom of main reservoir 
• One-way valve above filter 
prevents backflow 
• Main reservoir diameter sized to 
fit 5th percentile female hand size 
• No coarse filter 
• Attachment of internal filter is 
unclear 
• Plunger handle is difficult to 
interface with (human factors) 
Gamma Design 
 
• Fine internal filter removes 
smallest clots and particulates 
• Coarse internal filter 
• Three one-way valves allow 
greater control over fluid 
movement 
• Exit valve to blood bag at bottom 
of main reservoir 
• O-ring on plunger creates airtight 
seal 
• Tapered tip for ease of 
manufacturing and greater 
operator visualization of field 
• Main reservoir diameter sized to 
fit 5th percentile female hand size 
• More optimal plunger handle for 
user comfort 
• Difficult to predict clogging of 
filters 
• Cavity to store clots may be too 
small 
• May need extension of inlet 
tube beyond tapered tip 
• Connection mechanism to blood 













9 Final Design Description 
9.1 Prototype Design 
The final design is very similar in both form and function to the 
gamma design presented above. The only change to the gamma 
design is the addition of dowel pins at the end of the reservoir; these 
will prevent the plunger from being removed from the syringe 
housing. The device contains the following parts (Figure 13): tip 
(A), coarse filter (B), fine filter (C), main reservoir (D), swing check 
valve (E), O-ring (F), plunger (G), exit valve to blood bag (H), two 
duckbill valves (I), and a pair of dowel pins (J). 
9.1.1 Operation of device (Path of flow) 
The device operates by creating a negative pressure differential on 
the upward stroke of the plunger, which draws blood through the tip 
(A) and into the syringe reservoir (D), passing through the first 
duckbill valve (I), the two internal filters (B and C) and the swing 
check valve (E). The plunger is then forced downwards (down 
stroke), at which point the positive pressure closes the swing check 
valve and opens the duckbill valve at the exit to the blood bag. The 
blood then exits the main reservoir and is transferred into a blood 
bag which is connected to the outlet valve (H). This process is 
repeated in a continuous cycle until the blood intended for 
autotransfusion is completely evacuated from the patient’s abdomen.  
9.1.2 Part-by-part Description 
The tip (A) includes a rigidly attached internal filter (B) with a 
maximum pore size of 1 mm. This coarse filter will be used to 
remove larger clots before they reach the fine internal filter. The 
filter will be glued onto an internal lip (0.25” width) and has a 
diameter of 2.25”.  The tip also includes a hollow space beneath the 
filter, which is meant to store clots that are caught by that filter and 
reduce clogging.  
The second filter (C) has a maximum pore size of 170 μm and is 
attached in a rigid housing element with a height of 0.5” inside 
the main reservoir housing. A filter with a pore size of 37 μm 
was obtained from a distributor in hopes of modifying it to suit our needs.  The height of the 
housing element can be varied as needed to accommodate the filter, but is currently set to 1.5”. 
The next element the blood will encounter is a rubber swing check valve with a 2.25” diameter 
(E), which will be glued to a 0.125” lip in the housing of the main syringe. The valve will 
function like a torsional spring, opening on the up stroke of the plunger and closing on the down 
stroke. 
The handle on the plunger allows the user to fully grasp the plunger when pulling upwards. 











Figure 13: Exploded assembly 
view of final design 
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removed from the reservoir housing. This is a safety mechanism which prevents accidental 
disassembly of the device and protects clean blood from environmental exposure. In this 
position, the reservoir will be filled with clean blood, and the plunger can be pushed down, 
forcing the duckbill valve at the outlet blood bag connector (H) to open and closing the swing 
check valve and the duckbill valve at the inlet. Blood is then fed into a blood bag. Ideally, each 
stroke of the device will fill an entire blood bag; at this point, the filled bag will be removed from 
the device.  
The bag is then hung on an IV stand and transfused through an IV kit (which will control the 
infusion rate and prevent air embolisms using a drip chamber). Anticoagulant will not be 
introduced into the system, but is already present in the blood bag and will help prevent new 
clots from forming. This design will allow the syringe pump to operate continuously without 
overflow until the attached blood bag is filled, at which point operation can be paused while a 
fresh, empty blood bag is exchanged for the full one.  
Another option to prevent the need to frequently pause operation to change the blood bag would 
be to split the outlet line to feed multiple blood bags simultaneously. The outlet could also 
connect to an additional reservoir so that the entire procedure can be continuous. The full bags 
can then be hung on an IV stand for transfusion, while salvage of blood from the abdominal 
cavity continues. 
9.2 Final Design 
The final design does not differ significantly in form from the prototype. The only change is that 
the dowel pins at the end of the reservoir will be replaced by a c-clip (Figure 14). This was not 
done in the prototype because we were unable to find a clip in an appropriate size with internal 
pins. 
 
The primary differences between the prototype and the final product are in the materials and 
manufacturing processes. The prototype was constructed out of Plexiglas® for ease of 
manufacturing and availability of stock material. Manufacturing consisted of turning and milling 
operations. However, the main body and plunger of the final design will be composed of 
Makrolon® polypropylene and manufactured using injection molding.  
 
Figure 14: Final design CAD with close up of c-clip 
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9.3 Design Decisions 
9.3.1 Final geometry 
The final geometry of the design was driven by two elements: functional needs and associated 
human factors. The main functional driver behind the dimensions of the reservoir was the 
minimum volume specification of 450 mL. We aimed for a volume of 500 mL to allow for the 
possibility of accidentally aspirating air into the device; our final geometry yields a 488 mL 
reservoir. The other dictating factor in the final geometry was the 5th percentile adult female 
hand size, which limited the maximum diameter to 2.5”. Similarly, the handle size on the plunger 
was dictated by the need to maintain the structural integrity of the piece while accounting for the 
95th percentile adult male hand size. 
 
The diameter of the inlet valve was dictated by the maximum diameter of readily available 
duckbill check valves. The outlet diameter was chosen to interface with the standard blood bag 
tubing size. 
9.3.2 Check valves 
In designing this device, we investigated several different types of check valves. We began by 
looking at umbrella valves, but found that they didn’t allow a large enough area for blood to flow 
through at the inlet. At the outlet, they did not allow for flow in the correct direction. We then 
moved to duckbill valves, which allow for a larger diameter at the inlet and a different 
attachment mechanism at the outlet. 
 
Until this point, we planned to place the inlet valve above the filter; however, the adoption of the 
duckbill valves necessitated movement of the valve. The largest diameter duckbill valve we were 
able to obtain has an outer diameter of 0.63”. A filter of this size would clog too rapidly for our 
purposes, meaning that the diameter of the filter would need to be larger than that of the duckbill 
valve. Therefore, we switched the locations of these two components. This change necessitated 
the addition of a third check valve above the filter to prevent flow of filtered blood backwards 
through the filter on the down stroke of the plunger. Because we were unable to find an 
appropriate manufactured check valve, Bob Coury suggested that we design and fabricate a 
simple rubber swing check valve. 
9.3.3 Tapered tip 
We chose to add a tapered tip to the design for a number of reasons. First, the tip will now be 
used to store large clots that are filtered out by the first, coarse internal filter. This function 
means that we needed to have an enclosed volume at the tip of the device. Rather than simply 
extending the cylindrical body of the device, we chose to modify the tip, which provides this 
storage volume without further obstructing the user’s view of the operating field. 
9.3.4 Reusable vs. disposable 
One of the major changes in our final design compared to previous iterations is that it is entirely 
disposable. Early designs were intended to be reusable with a few disposable parts. To justify 
this decision, we completed a preliminary cost analysis comparing the cost per unit to produce a 
reusable and a disposable device with the same geometry. Additionally, it is worth noting that 
the design for a reusable device would be slightly different from that for a disposable device; in 
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the reusable version, the filters would need to be removable. This factor has the potential to 
further complicate the manufacturing process. 
The recorded cost of our targeted disposable polypropylene material (discussed further in Section 
11) from Techapro was around $4 per a pound. The cost of Topas’ autoclavable COC resin 
material was quoted at $7 per pound; if this material was used, the device could be autoclaved up 
to four times (validated by manufacturer specifications). Materials such as glass, which can have 
extensive life spans in the autoclave, were original considered, but rejected due to its tendency to 
shatter when dropped in addition to the manufacturing complexity of the design. 
The volume of materials in the plunger, reservoir, and tip is 26.9 in3. With Topas having a 
density of 0.037 lb/in3 and the medical grade polypropylene having a similar density of 0.0308 
lb/in3, the resulting plastic material cost per unit was $6.97 for the Topas and $3.31 for the 
polypropylene. Other costs of the device included the $12 filter from Terumo Cardiovascular and 
small accessories such as the valves from Vernay and the O-ring from McMaster. 
After consulting an industry professional, we concluded that the injection mold for 
manufacturing would cost in the range of $10,000 (Lapish). We then assumed production and 
distribution of enough units for one million uses, which would result in sales of 1 million units of 
the disposable polypropylene and 250,000 units of the reusable Topas. The resulting cost of the 
mold per unit was 10 cents for the disposable unit and 40 cents for the re-usable device. 
The price of filters for the reusable device was set 25% higher than those in the disposable 
because of the additional manufacturing complexity that a removable cartridge and packaging 
would entail, as well as the additional distribution costs. A cost of 4 units was first directly 
calculated, since the reusable design must to be used four times to be fully utilized. We were 
then able to calculate a flat unit cost (Table 8). These calculations, assumptions, and 
conversations with industry professionals validated our decision to move forward with the 
disposable design.   
Table 4: Projected cost of disposable and reusable parts 
 
Cost Disposable (# of parts) Reusable (# of parts) 
Plastic Material $3.31 (4) $6.97 (1) 
Filter $12.00 (4) $15.00 (4) 
Mold $0.10 (4) $0.40 (1) 
Accessories (Valves & O-ring) $2.00 (4) $2.50 (4) 
Cost for 4 units $65.64 $77.37 
Cost per unit $16.41 $19.34 
10 Engineering Background  
10.1 Blood Biochemistry 
Blood is made up of cells (and cell fragments) suspended in a liquid called plasma. The plasma 
contains dissolved proteins, metabolic wastes, and other molecules being moved between organs. 
There are two main types of cells present in blood, erythrocytes, or red blood cells, and 
leukocytes, or white blood cells. Erythrocytes make up 99% of the blood cells and are 
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responsible for carrying oxygen through the circulatory system. Leukocytes are part of the 
immune system and help protect the body against infection and cancer. The cell fragments 
present in blood are called platelets and function in clotting when blood vessels are damaged. 
The components of blood can be separated by centrifugation. The erythrocytes sink to the bottom 
of the centrifuge tube, and the plasma rises to the top. Platelets and leukocytes form the “buffy 
coat” between the layers of plasma and erythrocytes (Windmaier, 2006). If the blood is allowed 
to clot, the remaining fluid is termed serum. Serum is similar to plasma but lacks the protein 
fibrinogen (Mark, 2003).  
 
There are several different methods to measure the amounts of each blood component.  The 
percentage of blood volume that is intact red blood cells is defined as the hematocrit level. 
Normal levels of hematocrit are 45% in men and 42% in women. Hemoglobin concentration 
measures the concentration of the major oxygen-carrying pigment hemoglobin in whole blood. 
Normal levels of hemoglobin are 15 g/dL in men and 13.8 g/dL in women. The actual number of 
erythrocytes in a specific volume of blood (termed the RBC count) can also be calculated. 
Normal counts in men are 5.2 million cells/µL, and 4.6 million cells/µL in women (Schrier, 
2009).      
 
Anemia is a medical condition defined as a reduction in one of the measurements previously 
discussed. Anemia can be caused by a very wide variety of factors. Ruptured ectopic pregnancy 
patients almost always present with anemia due to hemorrhage. There is no exact lower limit to 
what is considered a normal hematocrit/ hemoglobin/ RBC count and what is anemic. The World 
Health Organization criteria for anemia are hemoglobin levels of <13 g/dL for men and <12 g/dL 
for women. However, these levels were intended to be used for nutritional evaluation rather than 
for a standard in the diagnosis of anemia (Schrier, 2009). Patients that present to hospitals in 
resource limited areas with ruptured ectopic pregnancy typically have a preoperative hematocrit 
of around 20% (Selo-Ojeme D. O.-W., 2007), which is less than half the normal level and clearly 
falls into the anemic range.  
 
As previously discussed, high pressures can cause hemolysis of red blood cells. Hemolysis 
occurs primarily through mechanical injury to the cells caused by air bubbles that expand and 
collide with the cells, generating mechanical stresses. Thus, aspiration of air should be avoided 
whenever possible to reduce the incidence of hemolysis. Dilution of the blood with saline is an 
option to consider. Adding saline in a ratio with blood of approximately 1:1 reduces the 
incidence of hemolysis by 55-60%, even at suction pressures of 300 mmHg (Waters, 2007).    
10.2 Fluid Mechanics 
Fluid mechanics will be the most important relevant scientific field related to the function of the 
device. As the device will be dealing primarily with blood, it is important that we fully 
understand the fluid dynamics of blood for the device to function as needed.   
Hemodynamics:  
Although whole blood is technically a non-Newtonian fluid, a good approximation is that it may 
be considered a Newtonian fluid at vessel diameters greater than 0.3 mm, and above shear rates 
of 100 sec-1 (Mark, 2003).  We will be using tubing significantly larger than 0.3 mm in diameter; 





Whole blood has an average viscosity of about 4 centipoise and is incompressible (constant 
density). This is about 4 times higher than the viscosity of water  (1centipoise) (Mark, 2003).  As 
whole blood is a non-Newtonian fluid, the viscosity is dependent on the shear rate.  Specifically, 
whole blood is a shear-thinning fluid, as apparent viscosity decreases with increasing shear rate.  
There are two factors that contribute to this: cell aggregation at low shear rates and erythrocyte 
deformation at high shear rates (Figure 14).  Erythrocyte aggregation occurs in the presence of 
fibrinogen and globulin, two plasma proteins. The erythrocytes stick together to form aggregates 
called rouleaux (Figure 15, top panel). These rouleaux are broken up as the blood flows at faster 
rates, decreasing the particle size and lowering the overall viscosity. Experiments have shown 
that the rouleaux are broken up into single cells at a shear rate of 10 sec-1 (Figure 15, middle 
panel). As the shear rate continues to increase, the apparent viscosity continues to drop. This 
phenomenon is attributed to the elongation of erythrocytes at high shear rates, which further 
decreases the viscosity (Figure 15, bottom panel) (Mark, 2003).      
 






Figure 16: Physiologic changes during increasing shear rates 
 
 
The viscosity of blood is also a function of hematocrit.  The amount of erythrocytes present in 
blood changes how the blood will respond to an applied force.  We can compile these factors 
influencing the viscosity of blood into a relationship that we can use to calculate the viscosity in 
a given circumstance to a more accurate level than simply using the average, 4 centipoise. If the 
shear rate is above 100s-1, the relationship is Newtonian and the viscosity is given in centipoise 
by: 
𝜇𝑁 = (0.00221) �𝑒
1965
𝑇 � (𝑒2.31𝑓) 
T is the absolute temperature of the blood in Kelvin and f is the fractional hematocrit value.  If 










Here,𝜀̇ is the strain rate,  𝜇𝑁 is the Newtonian velocity, given by the same equation used if the 
strain rate is above 100s-1, and  𝜏𝑦 denotes the yield stress of the fluid expressed in dyne/cm2.  




𝜏𝑦 = (𝑓 − .01)2(𝑐𝑓 + .05)2 
 
In the above relation, f is the fractional hematocrit of the blood, and cf is the concentration of 
fibrinogen expressed in g/dL (Qamar, 2010). These relationships will be important to consider as 
we further examine the operation of the device. In order to perform any type of velocity, flow or 
pressure calculation, we will need to know the viscosity of the fluid we are working with.  
 
We will need to perform an analysis of the flow dynamics of the device, regardless of the form 
of the final design, to ensure that it meets all relevant engineering specifications. Flow rate and 
pressure will be the two most important parameters to consider. The flow rate must meet the 
specification of 10 L/min without exceeding the maximum pressure of 150 mmHg that can 
damage the red blood cells. The balance between these two parameters is both our design driver 
and our most difficult challenge. We will need to make decisions regarding the dimensions, 
force, volume, suction pressure that comprise the device in order to ensure these two 
specifications are simultaneously met.   
 
Classification of Flow 
There are several different fluid dynamics principles we will need to utilize to characterize the 
flow of blood through the device. First, we will need to determine if the flow is laminar or 
turbulent. This accomplished by calculating the Reynolds number, which is an expression of the 







where ρ is the fluid density, v is a characteristic velocity, µ is the fluid viscosity and L is a 
characteristic length. When analyzing flow in a tube, as we will be for our device, the 
characteristic velocity is the average velocity and the diameter of the tube is the characteristic 
length. In cylindrical tubes, the flow is defined as laminar when Re<2100.  Turbulent flow 
occurs when Re>4000.  The intermediate region is termed the transitional flow region, where the 
flow is unstable and intermittently turbulent (Truskey, 2004).   
 
Bernoulli Equation 
The Bernoulli Equation relates parameters of a fluid flow along the same streamline.  The use of 
the equation is restricted to certain flow situations.  Viscous effects are assumed to be negligible, 
the flow is assumed to be steady and incompressible and the equation must be applied along a 





𝜌𝑣2 + 𝜌𝑔ℎ = 𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡 
 
Depending on our final calculation of the Reynold’s number, the Bernoulli equation may or may 
not be a reasonable approximation of the flow.  High Reyonld’s number flows are dominated by 
inertial forces, and the viscous forces can be considered negligible.  If the Reynold’s number of 
the flow is large, the Bernoulli equation would be a reasonable approximation to the flow and we 
can forgo attempting to estimate the exact viscosity of the blood.  If the Reynold’s number turns 
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out to be small, viscous forces will dominate the flow and we will have to use one of the 
following equations to characterize the flow (Munson, Young, Okiishi, & Huebsch, 2009).   
 
Conservation of Mass 
We can also use the principle of conservation of mass. The conservation of mass holds for any 
type of flow and any type of fluid, and thus will be relevant no matter what results from the 
previous flow and viscosity calculations. Blood is an incompressible fluid, so we can write the 
conservation of mass as: 




This can also be written in an alternative formulation as the continuity equation: ∇�⃗ ∙ ?⃗? = 0 (34) 
where ∇ is the del operator denoting the gradient.   
 
Conservation of Momentum 
We can also utilize the conservation of momentum, commonly called the Navier-Stokes 
equation.  Like the conservation of mass, Navier-Stokes can be applied to any flow conditions 





+ 𝜌�?⃗? ∙ ∇�⃗ �?⃗? = −∇�⃗ 𝜌 + 𝜇 ∇2 ?⃗? + 𝜌?⃗? 
 
The fluid density is denoted ρ, the viscosity µ, the velocity vector ?⃗?, and the gravity vector ?⃗?. 
The complete Navier-Stokes equation is rarely used without simplifying assumptions, as very 
few exact solutions have been found (Mark, 2003).   
 
Poiseuille Flow 
One of the exact solutions to the Navier-Stokes Equation holds for laminar flow in a tube. If we 
determine the flow through the device to be laminar, we will be able to use Poiseuille’s Law to 






(𝑃𝑎 − 𝑃𝑏) 
 
Here, a represents the radius of the tube, µ represents the viscosity; Pa and Pb represent the 
pressure at two different points along the streamline, with ∆𝑙 being the distance between them 
(Mark, 2003).  
11 Material Selection 
This section will describe the materials that were chosen for the prototype and the final design. 
11.1 Prototype Materials 
Since our prototype will demonstrate the function of the device only, we chose a material that 
would be easy to machine and is clear. This material did not need to be of medical grade as the 
initial prototype will not be tested on patients and will only serve as a proof of concept.  We 
chose Plexiglas (Cast Acrylic) to manufacture our prototype device. Plexiglas is not medical 
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grade and cannot withstand sterilization cycles but is easy to manufacture, inexpensive, and 
comes in standard stock sizes. A complete bill of materials can be found in Appendix 21.1.   
11.2 Final Design Materials 
The final design material selection was driven by the cost analysis that determined if our device 
would be disposable or reusable. The outcome of our cost analysis determined that our device 
should be disposable. Makrolon is a medical grade polypropylene polymer that is often used in 
medical devices that contact blood. This polymer is clear in color and inexpensive which makes 
it a good choice for use in a device that resembles a syringe. The material properties will allow 
each component to be made out of this material. Furthermore, Makrolon is supplied in pellets 
that can be easily used in injection molding machines, which is the manufacturing process that 
our final design will use.   
12 Parameter Analysis 
The analysis of the device parameters was completed using the material properties of medical 
grade polypropylene, shown in Table 5 below.  
Table 5: Material properties of medical grade polypropylene (Ensinger) 
Density 0.92 
Yield Strength 33 MPa 
Young’s Modulus 2,068 MPa 
Flexural Modulus 1,380 MPa 
Hardness 100 MPa 
Impact Resistance 690 J/m2 
 
12.1 Whole Device 
12.1.1 Impact Force 
Because the entire device is handheld, it has the potential to be dropped onto a hard floor and 
break due to the impact force. We can treat the device as a mass, m, falling from a height, h, onto 
a structure (the floor) which deforms to absorb the energy of the mass. The maximum velocity at 
which it impacts the floor can be easily calculated using the principle of conservation of energy. 
ghvmvmghKEPE ff 22
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where d is the distance the device travels after impact with the floor. This distance is dependent 
on the material properties of the floor. 
  
A second method for determining the impact force uses the definition of force as the change in 



















Here the problem is in estimating the time needed for the device to stop moving. As yet we have 
been unable to find a method to estimate this value. The method for determining the 
deformations of the floor also depends on estimates of the strain of the floor, and since we would 
also be choosing a floor material arbitrarily, this equation also results in unsubstantiated 
quantities for the impact force. Therefore, we have chosen to disregard this analysis with the 
assumption that our device will be manufactured from material that is already being used in 
handheld, disposable medical devices that has undergone rigorous testing in this area. 
 
The components of our device most prone to failure due to an impact force are the tip, the exit 
valve to the blood bag, and the handle of the plunger. The tapered support in the current tip 




The plunger could be subject to torsion while it is in the extended position. The 95th percentile 
force for an adult male hand torque is 7.4 N-m (Woodson, 1992). The plunger can be modeled as 
a beam with a cross sectional area shown in Figure 16 and corresponding polar moment of 


























= −τ  
The maximum shear stress can then be translated to the plane stress using the principles of 








Figure 17: Simplified cross section of the plunger 
38 
 
The yield strength of the material is 33 MPa, giving a safety factor of 7.2. This models the 
behavior of the plunger if it were rigidly attached to the reservoir tube. In reality, the plunger will 
rotate in torsion, with a frictional force created by the interference fit of the rubber ring. The 
maximum torque will be lower than this value, resulting in an even larger safety factor. 
12.2.2 Bending 
The position at which the plunger has the largest bending moment is when it is fully extended 
from the reservoir, supported only by the O-ring at the end. If a perpendicular force is applied to 
the end of the plunger and it is modeled as beam which is rigidly attached at one end, the 
































Because the reservoir tube and the plunger are composed of the same material, it is only 
necessary to analyze the failure of one of these. These results yield a safety factor of 1.3. While 
this is a low value, it is unlikely that the total 240 N force will ever be exerted completely 
perpendicular to the plunger; there will likely always be a parallel component, reducing the 
bending moment.  
12.3 Reservoir 
12.3.1 Hoop Stress 
The reservoir will be subject to a hoop stress applied by the user in gripping the reservoir during 
operation of the device. That stress was modeled using the following assumptions: 1) grip force 
of 622 N (95th percentile of adult males); 2) uniform pressure around the reservoir. The hoop 




Figure 18: Simplified plunger diagram 
D = 3.5 in = 0.0889 m 
H = 8.43 in = 0.214 m 
F = 54 lb = 240 N 
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376.2 kPa is well below the yield strength of 33 MPa (with a safety factor of 88), so the reservoir 
will not fail. 
12.4 Check Valve 
We were unable to find a large check valve that could interface with the large inner diameter 
(2.25”) of our device.  Therefore, we decided to manufacture our own swing check valve out of 
rubber that will fit our large tube diameter in the reservoir.  However, to ensure that the valve 
will open under the negative pressure in the reservoir tube, we performed a beam deflection 
calculation with one end fixed and a point load centered in the middle of the beam. 
 








Our specification does not dictate a minimum force on the plunger, only that the maximum force 
should be less than 43 N. Therefore, we chose a representative small force (P) of 2.5 pounds (a 
pressure of 1 psi in the reservoir tube over an area of 2.5in2). The disc was simplified as a square 
of uniform cross section (1.5” x 1.5”) for the calculation of beam deflection. The corresponding 
a value was 0.75” and the l value was 1.5”.  The moment of inertia (I) of the beam was 
calculated as 3
12
1 tl ⋅ , where t is the thickness of the rubber (1/8”).  The Young’s modulus (E) 
provided by the manufacturer of the rubber was 5500psi.  The resulting maximum deflection was 
determined to be 3.6”, which means that the valve will open under a pressure of 1psi, and will 







12.5 Dowel Pins  
The plunger will apply a shear force (F) on contact to the two dowel pins (Figure 20).  The dowel 





To calculate the force, F, required to shear the dowel pins we use 𝜏 = 𝐹
𝐴
 where A is the area of 
the two dowel pin surfaces in shear and 𝜏 is the shear strength of the stainless steel.   
The area for the two dowel pins is calculated to be 35.63 mm2.  Therefore, the force required to 
shear the dowel pins is 6600 N which greatly exceeds the forces that will be applied on the 
plunger. 
12.6 Fluid Flow in the Device 
There are several different parts of the device in which we must characterize the fluid flow. We 
begin with the basic force equation, 𝐹 = 𝑚𝑎. We are going to make the simplifying assumption 
that the applied force to the plunger is constant, although few people would be able to apply a 









   
 
As the weight of the fluid is much more significant than the weight of the plunger, we will 
neglect the weight of the plunger for now. We will also neglect kinetic friction.  It is difficult to 
determine the kinetic friction in this case using the normal equation 𝐹𝑘 = 𝜇𝑘𝑁. There is no 
normal force due to the weight of the plunger, as the friction force acts completely perpendicular 
to gravity.  Rather, the sealing pressure of the O-ring around the plunger caused by the 
interference fit creates the normal force. Additionally, the coefficient of kinetic friction is 
dependent on the velocity of the plunger, and is not constant in time. Assuming a constant 
plunger velocity of 100 mm/min, the friction force of a typical 3-piece syringe traces a curve of: 
 
Fapplied 
Fkinetic friction  
mplunger g 
Fkinetic friction  
mfluid g 
F D 
Figure 20: Shear force on dowel pin 




Figure 22: Friction force (Tsukruk, 1999) 
In Figure 22, the top curve shows the friction force when using a basic silicone lubricant. The 
bottom curve shows the forces generated when the syringe barrel is treated with plasma to 
crosslink the lubricant and reduce the force. 
 
Inclusion of kinetic friction when examining the plunger introduces a high degree of complexity.  
Friction forces normally have to be experimentally determined, and are something we will have 
to consider when performing validation tests. However, friction will have the ultimate effect of 
lowering the velocity of the plunger (and subsequently the fluid) so we do not anticipate that is 
will cause a harmful increase in pressure. 
 
Returning to our basic force equation, we now are examining only two forces, the applied force 
in the +y direction and the weight of the fluid in the –y direction. As the mass of the fluid 
changes as the plunger is pulled back, we must produce an equation for the mass of the fluid as a 
function of time. This mass will be a piecewise function, as the suction tube fills prior to the 
barrel. We will define the first phase of filling as the time before the suction tube is full, and the 
second phase of filling as the time after the suction tube has filled and the barrel is filling. 
 
𝑚 = 𝜌𝑉 = 𝜌𝜋𝑟2 
 
𝑚 = �𝜌
(𝜋𝑟12ℎ1),                           𝑚 ≤ 𝑚1
𝜌(𝜋𝑟12ℎ1 + 𝜋𝑟22ℎ2), 𝑚 > 𝑚1
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Here, parameters with a ‘1’ subscript denote the suction tube, while those with a ‘2’ denote the 
barrel.  m1 denotes the mass of the fluid in the suction tube, which does not change in time once 
full.  The heights are related to the velocity of the plunger. We know that h2 increases at the same 
rate as the plunger speed v, which means that h2 can be expressed as 𝑣 ∙ 𝑡. We can then rewrite 
the mass equation as: 
 
𝑚 = �𝜌
(𝜋𝑟12ℎ1),                           𝑚 ≤ 𝑚1





The speed at which h1 increases is also related to the velocity of the plunger v. We can equate 
these parameters using the flow rate of blood through the device: 
 
𝑄 = 𝐴1𝑣1 = 𝐴2𝑣 
 







This means that we can express h1 as a function of v. This gives us: 
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𝜌(𝜋𝑟12ℎ1 + 𝜋𝑟22𝑣𝑡), 𝑚 > 𝑚1
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𝜌𝜋(𝑟12ℎ1 + 𝑟22𝑣𝑡)
, 𝑚 > 𝑚1
  
 
Using the definition of acceleration as the time rate of change of velocity, we can integrate this 
equation to obtain the velocity of the plunger as a function of time. Looking first at the first 




































ln 𝑡 + 𝐶 
 
We can disregard the negative case, as it does not make sense to have negative velocities of the 




ln 𝑡 + 𝐶, 𝑚 ≤ 𝑚1  
 
We would like to be able to use the initial condition that the fluid starts out as stationary 
(V(0)=0), but as the natural logarithm of zero is undefined we cannot. Therefore, in order to 
determine an approximate value of the constant of integration C, we will choose a small value of 








, 𝑚 ≤ 𝑚1  
 

















This differential equation is not separable, and we must use numerical methods to find an 
approximate solution. This can be accomplished through the MATLAB function ode45. This 
function accepts a differential equation, time interval and initial condition as inputs and outputs a 
vector of numerical solutions. In our case, the initial condition is the speed of the fluid in the 
suction tube when it enters the barrel at some non-zero time.   
 
At this point, we can use a range of radii and heights for both the barrel and suction tube to see 
what kinds of fluid velocities we obtain based on the geometries. We will then be able to relate 
the velocities to the pressure in the fluid to determine we are exceeding our maximum pressure 
limit of 150 mmHg, which could constrain what geometries we can use in the design of the 
device. Given some of the initial benchmarking specifications with the vacuum aspirator and the 
volume necessary to hold in the syringe, we determined an initial reasonable range of geometries 








Table 6: Range of geometries 
Geometry: Minimum (cm): Maximum (cm): 
Suction tube radius (r1): 0.5 2 
Suction tube height(h1): 3 7 
Barrel radius (r2): 2 5 
Barrel height (h2): 5 20 
 
We can use these ranges to create a vector in MATLAB to find the range of velocities of the 
plunger based on the specific geometry. We can also input a range of values for the applied 
force. Based on our evaluations of anthropometric data, the maximum force exerted on the 
plunger (95th percentile of male pulling force) is 199.2 N (Wagner, Birt, Snyder, & Ducanson, 
1996). Returning to our first equation where the suction tube is filling, there are three variables 
that influence the plunger velocity; r2, F and t. This makes plotting the influence of all three at 
the same time impossible without creating an animation in time. Thus, we will choose three 
representational values (Table 7) of the geometries and one force value in order to examine the 
effect of time on the plunger speed. We will choose the minimum, maximum and average 
geometries to ensure that we are analyzing the full range of possibilities.  
 
 
Table 7: Values to Analyze 
Geometry: Value1 (cm) Value2 (cm) Value3 (cm) 
Suction tube radius (r1): 0.5 1.25 2 
Suction tube height(h1): 3 5 7 
Barrel radius (r2): 2 3.5 5 
Barrel height (h2): 5 12.5 20 
 
We will use 199.2 N as our chosen force, as it represents the maximum that theoretically could 
be applied to the plunger.  Computing the velocities in MATLAB, we obtain: 
 































As expected, smaller geometries result in higher velocities of the plunger. We also note here, that 
our analysis produces extremely high velocities of the plunger. It is not reasonable to expect a 
user to pull back the plunger at 35 m/s or even 5 m/s.  This large magnitude of error could come 
from one of two primary sources. First, we neglected kinetic friction, which contributes 
significantly to the force opposing the movement of the plunger. Second, using the maximum 
human pulling force of approximately 240 N is also not physically realistic. Applying a 240 N 
force is equivalent to putting a 54 lb weight on the end of the syringe, a truly huge force 
considering the situation. If we run the code again using a more reasonable 10 N force, we 
obtain: 
 
These speeds of the plunger are significantly slower, but still are quite high, even for the larger 
geometries.  This error can again be attributed to neglecting the kinetic friction between the 
rubber O-ring and the interior of the device barrel.  We will continue with the analysis, however, 
to examine relationships among the parameters.   
 
We can now take the asymptotic values of the velocity of the plunger at the end of the first phase 
and use them as the initial condition for the second phase.  This is where we return to the 
equation for the velocity of the plunger that we must solve using numerical methods.  The 
MATLAB codes are provided in Appendix 20.11.  As MATLAB assigns the number of steps 
and step sizes used by the function, we cannot graph the solutions from the different value 
groups on the same plot.  We must plot them separately: 
































As we saw with the first phase, increased size of the device reduces the velocity of the plunger.  
These velocities are again much higher than we would expect, which is likely due to the 
contribution of kinetic friction.  We would expect the user to pull the plunger back at a velocity 
of about 1 cm/s, which is several hundred orders of magnitude lower than we obtained from the 
analysis.  
 
We can now take the velocity of the plunger and work the different fluid parameters.  Due to the 
no-slip condition, we can assume that the velocity of the fluid against the plunger is the same as 







In this formulation, ρ is the fluid density, v is a characteristic velocity, µ is the fluid viscosity and 
L is a characteristic length. When analyzing flow in a tube, the characteristic velocity is the 
average velocity and the diameter of the tube is the characteristic length. In cylindrical tubes, the 
flow is defined as laminar when Re<2100.  Turbulent flow occurs when Re>4000.  The 
intermediate region is termed the transitional flow region, where the flow is unstable and 
intermittently turbulent (Truskey, 2004).  When Re <<1, the flow is dominated by viscous 
effects, and when Re>>1, it is dominated by inertial effects.   
 
The density of blood is 1060 kg/m3 (Cutnell & Johnson, 1998) and we will choose 3.5 cm as our 
tube diameter (average of upper and lower range). We will estimate on the high side and choose 
1 m/s as our characteristic velocity to account for the increased velocity in the smaller-radius 
suction tube (as well as the entry to the blood bag).  We will use the average density of blood, 
measured at .004 Poise (Mark, 2003).  This gives us a Reynolds’s number of 9275, which is in 
the laminar region where inertial effects will dominate the flow.  This means that we can 
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reasonably approximate the fluid as inviscid and model it using the Bernoulli equation.    The 
Bernoulli equation relates two points on a streamline.  We can consider a point in the blood still 
contained in the body cavity (subscript 0), a point in the suction tube (subscript 1), and a point in 









𝜌𝑣02 + 𝜌𝑔ℎ0 = 𝑝1 +
1
2
𝜌𝑣12 + 𝜌𝑔ℎ1 = 𝑝2 +
1
2
𝜌𝑣22 + 𝜌𝑔ℎ2 
 
When the blood is still in the body cavity, it has no velocity and we can define the pressure and 
height there as 0.  This simplifies the equation to: 
 
0 = 𝑝1 +
1
2
𝜌𝑣12 + 𝜌𝑔ℎ1 = 𝑝2 +
1
2
𝜌𝑣22 + 𝜌𝑔ℎ2 
 
If we assume that the device is held straight up, we can use the vector of heights from our 
previous analysis as input to h1 and h2.  Our previous analysis also gave us the velocity of the 
fluid in the barrel v2.  This means that we can solve for the fluid pressure in the barrel after 




𝜌𝑣22 − 𝜌𝑔ℎ2 
 
Using MATLAB, we can plot the pressure as a function of the height of the tube and the 
velocity.  We will use the same range as provided in Table 7 and add the height of the suction 
tube since we have set our zero to be at the bottom of the suction tube. As previously discussed, 
the velocities we obtained from our analysis of the plunger were not physically realistic, so we 
will use a range of velocities of the plunger from 0 – 0.5 m/s to ensure we are including all 






We can see here that even at the smallest geometries and highest velocities we are well under the 
pressure limit of 150 mmHg.  We can repeat the procedure for the pressure in the suction tube.  
We must first relate the velocity in the suction tube to the velocity in the barrel through the flow 
rate: 
𝑄 = 𝐴1𝑣1 = 𝐴2𝑣2 
 
We can take the range of areas based on the range we set for the radii of both the suction tube 
and the barrel and the velocity range we used for v2 and obtain the range of velocities v1 in the 
suction tube to be 0 – 3.125 m/s.  We can then rearrange the Bernoulli equation to find the 
pressure in the suction tube: 
0 = 𝑝1 +
1
2
𝜌𝑣12 + 𝜌𝑔ℎ1 = 𝑝2 +
1
2





𝜌𝑣12 − 𝜌𝑔ℎ1 
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We can see here as well that for all the possible fluid velocities and geometries the pressure is 
still well under 150 mmHg.  This means that we can freely choose dimensions of the device 
based on human factors within our ranges without exceeding the pressure limit.   
 
We can also evaluate the pressures generated in the connection to the blood bag.  We have to 
reset our zero point in the Bernoulli equation, as the blood in the IV tubing is not on the same 
streamline as we used previously.  The two points we are now comparing are a point in the barrel 





𝜌𝑣22 + 𝜌𝑔ℎ2 = 𝑝3 +
1
2
𝜌𝑣32 + 𝜌𝑔ℎ3 
 
We can choose a point in the barrel such that h2=h3.  We then can rearrange the equation for p3: 
 








𝑝3 = 𝑝2 +
1
2
𝜌(𝑣22 − 𝑣32) 
 
For p2, we can input the pressure array we got previously, which gives us a range of about 0-24 
mmHg.  We will use the same range of velocities of v2, and can relate them to v3 through the 
flow rate:   
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The diameter of standard IV tubing ranges from 3-6.4 mm, which we can use to calculate a 
minimum and maximum area of A3.  We get that v3 can range from 0-122.07 m/s.  This upper 
limit is quite fast, which is not unexpected as the diameter of the IV tubing is so small.  Plotting 
the pressures in MATLAB, we get:      
  
 
The pressures generated in the IV tube are much higher than those that occur in the suction tip or 
in the barrel, and some exceed the limit of 150 mmHg.  We will need to keep the diameter of the 
tubing as wide as possible to reduce the velocity through the tube.  If we use the upper limit of 
the tubing size, 6.4 mm, we can calculate the velocity of the fluid in the tubing (using the same 
procedure as previously) as 1.22 m/s, a much more reasonable value.  If we use this value and 
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This shows that as long as we use the maximum size tubing in the IV line, we should not 
generate pressures greater than 150 mmHg. 
  
The final parameter to examine is the overall flow rate of blood.  We have used the flow rate to 
equate the different velocities, but have yet to calculate it for the whole device.  As the flow rates 
through the various parts of the device are equal, we can choose any one of them to work with.  
Let us choose the syringe barrel.  As stated previously, we have a radius range of 2-5 cm and a 
velocity range of 0-0.5 m/s.  Returning to the equation for flow rate, we have: 
 
𝑄 = 𝐴2𝑣2 
 
If we plug in the maximum values for the area and velocity, we end up with a flow rate of 23.6 
l/min, which is greater than the flow rate defined in our engineering specifications.  If we use the 
smallest area of the barrel and a minimum velocity of .01 m/s, we obtain a flow rate of .75 l/min, 
which is lower than our defined specification but still a fairly significant rate.  As the user will 
vary the pressure on the plunger, meeting the flow rate specification should not be much of an 
issue for the geometries used here. 
 
After finalizing the dimensions of the device based on human factors and available stock sizes of 
materials, we run the analysis again using our specific values.  We get: 
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These final plots illustrate the pressures occurring in the various parts of the device.  We can see 
that the pressures are under our 150 mmHg limit.  We must realize however, that the analysis 
does make simplifying assumptions and it is still vitally important that we perform validation 
tests to experimentally determine that the fluid pressure never gets too high. 
12.7 Relevant software analysis 
We learned a significant amount from running the material selection analysis in CES. The 
analysis allowed us to show that we are using the appropriate materials given our mass and cost 
constraints. Furthermore, CES also allowed us to select the manufacturing process that best fits 
the materials and tolerances that we require. CES provided information on the cost, speed, and 
efficiency of different manufacturing processes that allowed us to perform a detailed evaluation 
The SimaPro software allowed us to view the environmental impacts of the materials used in our 
device. We compared the two materials used in our device to one another to assess the 
environmental impacts. There is a significant environmental impact as a result of our device 
being disposable (short lifecycle) and the materials used being plastic. The data provided by the 
SimaPro program has allowed us to evaluate whether the device should be reusable or 
disposable. 
The design for safety program (DesignSafe) provided us the opportunity to thoroughly evaluate 
all safety considerations during the manufacturing of our prototype. We were also able to assess 
the risks of certain operations and perform a risk reduction using a list of suggested techniques. 
After running the analysis and risk reduction, we determined that all of our hazards were of 
either low or negligible risk severity. 
A more detailed discussion of the analysis provided by the software referenced above can be 
found in Appendix 21.3. 
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13 Prototype Manufacturing Plan 
Our initial prototype device was manufactured in four parts: suction tip, reservoir barrel, blood 
bag connector, and plunger. We also custom manufactured one swing check valve to fit the large 
inner diameter of our reservoir barrel.  The duckbill valves and the two filters were purchased 
from third party suppliers. 
13.1 Suction tip 
To fabricate the tip (Figure 23), we started with a stock 2.5” diameter cast acrylic rod and used a 
band saw to cut the rod to 2.75” in length. We then mount the rod onto a lathe and finished both 
ends of the rod, drilled and counterbored the inner diameters (C and D) of the opening in the 
suction tip. The part was then turned on the lathe and the larger openings (A and B) where the 
clots will be stored were bored out. The tool post was then moved on an angle with a cutting tool 
to create the taper (E).  
 
Figure 23: Isometric and side view of tip 
 
13.2 Reservoir barrel 
The reservoir barrel (Figure 24) was fabricated in two pieces (A and B) that were glued together 
using epoxy. We manufacture part A from a standard tube stock of cast acrylic (2.25” ID x 2.5” 
OD x 1’ H). The tube stock was cut to a length of 7.3” using a band saw and then milled to its 
finished length. One 0.5” diameter hole (C) was milled and reamed to create an interference fit 
for the blood bag connector. Two 3/16” diameter holes (D) were milled and reamed to create an 
interference fit for two dowel rods.   
Part B was manufactured from a stock 2.5” diameter cast acrylic rod. The length was cut down to 
1.3” using a band saw, and then milled to its finished dimensions of 1.15.”  A CNC mill was 
used to mill out the inner diameters of 2” (F) and 1.75” (E). To obtain the lip that will support the 
swing check valve and the fine filter, we used a boring operation on the mill. Once both parts are 









Figure 24: 3D cross section view of reservoir 
 
13.3 Blood Bag Connector 
The blood bag connector (Figure 25) can be created using a lathe. A standard stock 0.5” diameter 
cast acrylic rod was cut to a length of 2.2” using a band saw. This piece was then mounted in the 
lathe, and the inner diameters (A and B) of the rod were drilled and counter-bored to size. The 
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The plunger (Figure 26) for our device is made of complex features that would be difficult to 
machine in a lathe or mill.  We used 3D printing to produce a rapid prototype for this part. The 
specific machine that was used was a Fused Deposition Modeling (FDM) machine that can 
produce parts made of ABS plastic. This 3D printer works by laying down material in layers. 
Plastic filament is unwound from a coil and fed through an extrusion nozzle that toggles the flow 
of the material. The nozzle is heated to melt the material and can be moved in both horizontal 












13.5 Swing check valve 
We needed to manufacture our own swing check valve (Figure 27) as we were not able to find a 
ready-made check valve that will fit our internal diameter of 2.25”. The material used to make 
this valve was 1/8” thick polyurethane rubber with a Durometer of 90A shore. A laser jet was 
used to cut a circular shape of the valve with an outer diameter of 2.25” and a 330° arc with a 
diameter of 1.85”.  
 
Figure 27: Swing check valve 




The duckbill valve was first inserted using interference fit (Part A, Figure 25; Part D, Figure 23) 
into the suction tip and the blood bag connector. Next, the coarse filter glued onto the lip of the 
suction tip (Part A, Figure 23). Ideally, the fine filter will then be inserted into the hollow 
opening of the reservoir (Part G, Figure 24); however, we were unable to attach this filter in 
constructing our prototype. The swing check valve was then glued to the inner lip (Part E, Figure 
24) of the reservoir using epoxy.   
Once all of the internal accessories were fixed, the suction tip, reservoir and blood bag connector 
were assembled using epoxy. When the epoxy dried, the o-ring was attached to the plunger and 
then inserted into the top of the reservoir.  Finally, the dowel pins were press fit into the openings 
(Part D, Figure 21) on the reservoir barrel. 
14 Final Design Mass Manufacturing Plan 
The manufacturing process that we selected for the production of our housing (polypropylene) 
and plunger (COC) is injection molding. Injection molding is a quick manufacturing process that 
can yield the 100,000 units per year needed to meet demand. It can meet a production rate of 60 
to 3000 units per hour. Although the capital cost is high initially ($10,000 for the initial mold), 
we can expect to distribute this cost amongst the large volume of units manufactured. Injection 
molding is also an ideal process considering the tight manufacturing tolerances needed in the 
barrel of the syringe—to create the seal necessary with the o-ring, the inside diameter in the 
barrel must be consistent to within 0.001”. Therefore, extrusion processes will not work to create 
tolerances needed. Both parts (housing and plunger) are symmetrical around one axis and can be 
easily injection molded.   
The barrel will need to be injection molded in two parts: reservoir and suction tip. The blood bag 
connector can be attached in the mold of the reservoir. However, the suction tip and the reservoir 
will need to be separate pieces, as the filters and check valves will need to be inserted into the 
device prior to sealing it. Once the suction tip is molded, the fine and coarse filters will be 
inserted into the respective cavities and affixed using an adhesive. The large one way check 
valve and duckbill valves for the blood bag connector and suction tip will then be attached using 
a silicone adhesive. Once the filters and valves have been attached, the suction tip and reservoir 
can be connected together using a solvent adhesive. 
The plunger can be injection molded in a single part. The o-ring will then be placed into the slot 
in the plunger and silicone lubricant applied to allow for smooth operation. The final step for 
assembly will be placing the c-clip on the top of the reservoir to ensure that the plunger cannot 
be accidentally removed during operation.  
15 Validation 
Our final design met all but one of our user requirements (Table 8). The one requirement which 
was not met was that the total blood collected be measured to within ±10 mL. We could 
potentially add markings on the outside of the reservoir which would allow the user to visually 
recognize the amount of blood that has been collected and filtered. However, since we are 
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connecting the device directly to a blood bag, the more logical way to measure the amount of 
blood collected would be to track the number of blood bags filled. 
Table 8: Validation of user requirements 




y Removes particulate 
matter 
≥ 170 µm in diameter 




Does not damage  
cells 






Closed system 0 openings to environment Yes Closed submersion 




Force on plunger >45 N Yes Fully clogged force 
of 75±20 N 
Durable Withstand drop from 2 m Not relevant Different material 
used in prototype 
and final design 
Can manage 
significant blood loss 
≥ 2 L blood loss Yes Functional 
validation tests with 





Flow rate removes 
blood sufficiently 
≥ 0.5 L/min Yes Functional 
validation tests 
yield a flow rate of 
1.6±1.0 L/min 
Measures total blood 
collected 
≤ ±10 mL accuracy Not validated  
Easy to operate Training time < 30 min 
 
1 operator required 
 
 
< 5 steps for operation 
 

















Users received < 5 
minutes of training 
1 operator was used 
for functional 
validation tests 
Less than 5 steps 
were required 
Force applied to 
start movement of 
the plunger was 
35±10 N 
Diameter = 2.5 in 
 Low cost $10-15 No See cost analysis 
(9.3.4) 
 
Compatible with or 
replaces blood 
transfusion kit 
≥ 20 drops/min infusion rate 
≤ 450 mL blood bag volume 
 
Compatible with 3mm tubing 






Reservoir holds up 
to 488mL of fluid 
Blood bag can be 
attached using an 
adapter 
 
Quick to operate Set-up time of < 2 min 
Time to first transfusion is  
≤ 10 min 
Not validated 
Not validated 
No blood bag 
available to test 
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 Small and portable ≤ 15.5 kg filled Yes 920±80 g 
 
Quiet Operating level ≤ 50 dB Yes The noise from the 
device could not be 
detected as it was 
less than the 
ambient noise in the 
room 
 
15.1 Functional validation 
Functional validation tests were performed by two separate groups. In the first, trained users 
processed 2L of water through the device. The time to process was recorded, and the procedure 
was repeated ten times for each user. The processing time significantly decreased over the first 4-
5 trials, but reached a stable point of 60±15s over trials 6-10. This indicates that the device has a 
maximum potential comfortable flow rate during operation which is acceptable based upon the 
relevant specification (≥0.5 L/min). 
 
 
Figure 28: Time needed to process 2L of water over multiple trials (N=3) 
The second group processed 1L of water twice without any training (Table 9). Time to process 
significantly decreased after only one use, even without any formal training. 
Table 9: Process time for users with no formal training 
 Mean time [s] Mean flow rate [L/min] 
First use (N=21) 40±20 1.6±1.0 

































For both groups, the time needed to process 2L of water and the average flow rates meet our 
specifications of ≥ 0.5L. Furthermore, the device has been shown to be capable of processing 2L 
of liquid, can be operated by a single user, and requires less than 30 minutes of training time 
(since users unfamiliar with the device were able to operate it after only a brief, 5 minute 
conceptual description of the concept). Additionally, because the device is disposable, it would 
be presented to users fully assembled, so the only steps involved in readying it for use would be 
to connect it to the blood bag. 
 
A force gauge was used to measure the force needed to draw the plunger back when the device 
was fully submerged in water. The measured force was 35±10 N, which meets our specification 
of ≤ 48 N. Additional testing was performed, in which the tip of the device was fully clogged, 
and the force needed to pull back the plunger was measured. This resulted in a force of 75±20 N, 
which is significantly higher than the unclogged pulling force, and is noticeable to the users. 
15.2 Human factors validation 
The human factors associated with the device operation were tested through the use of a short 
survey. Subjects were asked to operate the device by processing 1-2L of water and then 
completing a survey regarding the comfort and ease of use. Subjects performed the operation 
twice; once to gain familiarity with the device (as novice users), and a second time as 
experienced users. The results of the survey are shown below. A score of 5 indicates that users 
strongly agree and a score of 1 indicates that they strongly disagree. 
 
Table 10: Human factors validation results (N=16) 
Human Factors Survey Results Mean Rank out of 5 
Device was easy to use  4.2±1.0 
Device was comfortable to hold  3.7±0.8 
Handle was comfortable to hold  3.9±0.5 
Was fatigued after completing the task  1.7±0.9 
 
Shown in Table 10, users found the device easy to use, with a strongly positive ranking of 
4.2±1.0. On comfort of both the device as a whole, and more specifically the handle, users had 
neutral to positive rankings of 3.7±0.8 and 3.9±0.5, respectively. This would indicate that a 
redesign of the device, and especially the handle, which weighs the human factors more heavily 
should be considered. Regarding the ease of operation, users ranked their fatigue after use as low 
to very low, with a score of 1.7±0.9. 
 
Additionally, more open questions were included in the survey. Specifically, we asked the users 
how long they thought they could operate the device without becoming fatigued; what would 
make the device easier to use; what would make the device more comfortable to use; what was 
the least comfortable part of using the device; and whether they would prefer an alternate handle 





Figure 29: T-grip and knob alternate handle designs 
Users reported a wide range of projected times for operating the device without fatigue, ranging 
from 30 seconds to 2 hours. The average time was 20 minutes, which is significantly longer than 
we would expect the device to be in operation (a specification of 5 minutes was set previously in 
section 5.3). 
Common comments regarding the ease and comfort of the device included the need for a grip on 
the barrel; a splash guard to prevent liquid from exiting through the back of the barrel (this 
happened frequently when the plunger was jerked, breaking the seal between the o-ring and the 
barrel); and a more ergonomic design of the existing handle. Specifically, users preferred the T-
grip handle design over the knob and the current square handle, although many commented that a 
more ergonomically designed version of the current handle would be ideal (a curved rather than 
square fit, rounded edges). 
16 Design Critique 
During the validation of our device, several design critiques were determined.  We divided these 
critiques into two categories: user critiques and functional critiques.  User critiques were 
provided to us by survey respondents and functional critiques were determined based on our 
engineering judgment during the use of the device. 
16.1 User Critiques 
The two user critiques that were consistently mentioned in the surveys were the comfort of the 
plunger handle and the lack of a grip on the reservoir. The current plunger handle is a rectangular 
grip that forces a user into a certain hand orientation that may not be the most ideal position for 
reducing fatigue. Furthermore, the plunger handle had several sharp edges which reduced the 
comfort in holding the device.   
The lack of a grip on the reservoir was the second user critique. During our validation tests with 
water, some residual water would frequently splash on the barrel of the device, making it very 
slippery during operation. Users would often grip the blood bag connector or the tip of the device 
to get an adequate hold on the device during operation. 
16.2 Functional Critiques 
Three functional critiques were determined during our validation testing: poor fitting of the 
duckbill valves, custom fit of the fine filter, and residual fluid left in the suction tip after use.  
The duckbill valves were attached to the device using superglue adhesive that bonds to rubber 
surfaces.  However, after a few uses of the device both duckbill valves (at the suction tip and 
blood bag connector) became loose and fell out of the seats. 
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The fine filter (170µm) that we obtained from a free sample of an arterial blood filter did not fit 
to the dimensions of our filter compartment. The filter mesh was also very thin and could not be 
adequately secured to the housing. Since the filtering capacity was severely diminished due to 
the poor fitting, we removed the fine filter during operation and validation testing. 
Residual fluid in the suction tip between the duckbill valve and the swing check valve amounted 
to 150mL after 2L of water was removed from the reservoir.  This is a substantial amount of 
fluid that was left within the suction tip that did not pass through the filtering chamber.  If this 
residual fluid had been blood, it would need to be discarded as it would not have been filtered. 
16.3 Recommendations 
16.3.1 Plunger Handle Design 
We propose that the two alternate handle designs discussed previously be further evaluated, in 
addition to the rectangular grip.  The knob and t-grip (Figure 29) are two grips that we believe 
may be more ergonomic by allowing the user greater flexibility in selecting a grip orientation.   
16.3.2 Reservoir Grip 
A rubber grip can be placed over half the circumference of the reservoir barrel that will give the 
users a better hold on the device during operation. The rubber grip should have indentations that 
allow fingers to fit comfortably without slipping. Additionally, it might be possible to reshape 
the barrel itself to create a better fit.  
16.3.3 Mechanical Fitting of Duckbill Valves 
We contacted the manufacturer of the duckbill valves and obtained additional information on 
attaching duckbill valves to a medical device. The manufacturer provided us with specifications 
for a mechanical fitting of duckbill valves. The mechanical fitting consists of a seat where the lip 
of the valve will sit and a mate that fits into the seat to compress the lip of the valve.  Once the 
lip of the valve is compressed, the duckbill valve will not fall out of place unless the mate and 
seat become loose. 
16.3.4 Reduction of Volume in Filtering Chamber 
The 150mL residual fluid that is left within the filtering chamber can be reduced by decreasing 
the volume in the chamber. The volume of the chamber is primarily determined by the size of the 
filters, so reducing both their overall size (not pore size) and the space between the coarse and 
the fine filters is key.  
17 Challenges and Recommendations 
17.1 Broad Challenges 
17.1.1 Design for Resource-Limited Settings 
Background: We encountered many challenges working on a medical device within the 
constraints of designing the device for resource-limited settings. The device must ultimately be 
sustainable in the segment that we are targeting. Sustainable technologies in this must be low 
cost and maintenance, composed primarily of locally available materials, and environmentally 
and culturally sustainable. During our one month ethnographic study, we were able to find 
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preliminary requirements and specifications addressing the issue of sustainability; however, our 
group does not have a complete understanding of the background of some of these specifications. 
We attempted to remain in contact with local mentors to continually refine our user requirements 
and specifications as they fit with the topic of a sustainable technology. We completed a 
preliminary survey of locally available materials and manufacturers while in-country. Each 
design report was sent to multiple local health care workers to ensure that our design remained in 
line with their expectations. 
Recommendation: This component of the design process was one of the most challenging. 
Logistical challenges prevented us from maintaining close contact with our local mentors and 
other contacts. Phone calls were difficult to schedule and email responses were often not 
received until several weeks later. If another group plans to complete a project in collaboration 
with a local team or mentor, they should make every effort to develop a close relationship while 
in country, which should help to facilitate a continued working relationship once the team has 
returned to the US. Additionally, we found that it was often easier to contact people who were 
not particularly high up in the hierarchy of the health care system, as they frequently had more 
free time and were more willing to spend that time advising us than, for example, senior 
physicians. 
17.1.2 Regulatory 
Background: The autologous transfusion device that we designed is classified as a Class II 
medical device by the FDA (21CFR868.5830). Class II medical devices present a unique set of 
challenges in regards to the design of the device. These devices must include specific labeling 
requirements and mandatory performance standards to ensure patient and operator safety, which 
will drive the design of our device. Additionally, medical device export laws and international 
medical device regulations for countries that our device may be applicable in. 
To help us with our challenges specific to medical device design, we require assistance from 
experts that have worked with medical devices in the past and have had experience working with 
the FDA and preferably international medical device regulations. We will design our device 
considering the impact of the FDA regulations in our specifications while continuing to research 
international regulations and revising our user requirements and engineering specifications as 
needed. We have contacted the International Transactions Clinic at the UM Law School, whose 
clients include providers of products at the base of the pyramid in emerging markets. Julia 
Papastavridis is our contact in the clinic, and is currently examining some of the regulatory 
issues surrounding the design and implementation of our device. 
Recommendation: Despite promising initial conversations, our contact with the International 
Transactions Clinic has been minimal at best during the semester. We should have made more 
attempts to interact with them and explain our situation so that we could fully utilize the 
resources they might have provided. As of now, we have only minimal knowledge of FDA 
regulatory procedures, and no knowledge of export law.  
17.1.3 Scope of Clinical Settings 
Background: During our one month ethnographic study at KATH, we identified our user 
requirements and engineering specifications as it related to our users at a main referral hospital in 
Ghana. However, in our initial research we have identified an additional scope of use in district 
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hospitals present in developing countries that may not even have a current procedure for 
autotransfusion. We would like to include district hospitals in resource-limited settings within 
the scope of our project, but face the challenge of identifying user requirements and engineering 
specifications as they relate to users in these district hospitals. 
During the semester, we researched the potential scope of use in district hospitals and the 
facilities available at these hospitals. Our contact at a district hospital in Ghana has stated that 
since 2005 there have been only 5 cases of ectopic pregnancy in her hospital. When a case 
occurs, the patients undergo surgery with blood transfusion units provided by blood donation 
from relatives, since there is no blood bank at the district hospital. Since this is anecdotal data 
from only one hospital, we are continuing to investigate the situation at district hospitals to 
determine whether this situation is representative of the country as a whole. Should we find that 
ectopic pregnancy rupture is a major issue in the rural hospitals, we will attempt to obtain 
sufficient information about the feasibility of such a device in district hospitals such that we can 
begin to translate these details into user requirements and engineering specifications. 
Recommendation: While in-country, it would have been very useful for the entire team to obtain 
first-hand experience of more rural and district hospitals. Instead, only one member of the team 
had ever visited a district hospital, and we had limited contacts in those environments. As a result 
it was often difficult for the team to design around users with whom we had never had any 
contact. 
17.1.4 Engineering Specifications 
Background: Our user requirements and engineering specifications were largely defined with no 
specific design in mind. However, many of the original requirements imposed design constraints 
(such as being electrically powered), and about half of them were focused on things which 
became irrelevant after the move to a disposable, human-powered device rather than a reusable, 
electrical one. 
Recommendation:  A broader definition of the user requirements would have been helpful during 
the initial brainstorming phase. Some of the requirements (such as the rate at which blood should 
be removed) were defined this way and others (such as electrically powered) were not. Because 
of this, when we moved to a disposable design, we were forced to radically adjust a number of 
requirements, which required significant investments of time and research. 
18 Summary and Conclusions 
The lack of blood available for transfusions in the developing world is a critically important 
challenge that will require solutions from multiple disciplines. Likewise, ruptured ectopic 
pregnancy is a true obstetric emergency and is the largest contributor to maternal mortality in the 
first trimester of pregnancy. We believe that there is a true need for an autologous blood salvage 
device that can help address the lack of donated blood and improve outcomes for patients. We 
focused on ruptured ectopic pregnancy as a case study for the use of this device.  
We generated our design requirements through an extensive interview process conducted with 
physicians, nurses, midwives, and technicians at Komfo Anokye Teaching Hospital in Kumasi, 
Ghana. These requirements were rank ordered through the use of surveys (Appendix 21.12). We 
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then translated these requirements into engineering specifications. These specifications were 
verified against the literature and current devices that perform similar functions. 
The two most important categories of design requirements and engineering specifications are 
safety and functionality concerns. It is vital that the patient not experience any serious 
complications as a result of using this device. At the same time, the device is also required to 
remove, filter and transfuse the lost blood in a timely manner. Creating a balance between these 
two broad-level requirements is essential in creating a feasible design. 
The concept generation phase of the design process comprised both component- and system-
level brainstorming. Our alpha design concept, which we dubbed the “giant syringe” emerged 
from this process. We have since undergone multiple iterations in the evolution of the design to 
produce our final design. The overall function of the original alpha design has been retained. The 
final design includes three check valves, which provide greater control over fluid movement; an 
o-ring to create an airtight seal between the plunger and the reservoir housing; and a hollow, 
tapered tip which is used to store larger clots that are caught by a coarse internal filter before 
blood passes through an additional fine internal filter. Physical comfort for the operator was also 
addressed, with the main reservoir diameter size fitting to the 5th percentile adult female hand 
size, and the inclusion of a plunger handle. 
The tip of the device is inserted into the body cavity during a surgical procedure and the plunger 
pulled back to remove the blood, which passes through two internal filters and into the main 
reservoir of the syringe. On the down stroke of the syringe plunger, a check valve prevents blood 
from passing back out through the tip; it is instead diverted through an outlet and into a blood 
bag, which is protected by a second check valve. Once in the blood bag, the filtered blood will 
mix with anticoagulant, and the filled bag can be hung on an IV stand for transfusion.  
Validation testing has proven the functionality of our initial prototype, with mean flow rates of 
1.6±1.0 L/min and 2.0±0.8 L/min for novice and experienced users, respectively, without any 
formal training. Additionally, the device was shown to be capable of processing 2L of liquid, can 
be operated by a single user, and requires less than 30 minutes of training time. Because the 
device is disposable, it would be presented to users fully assembled, so the only steps involved in 
readying it for use would be to connect it to the blood bag. 
Human factors testing revealed that while users were comfortable with the overall function of the 
device, there is room to improve in the design. Specifically, further analysis and redesign of the 
handle is recommended, as well as the addition of a grip or handle of some sort on the reservoir 
barrel, which will provide greater comfort for the user during operation of the device. 
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VL 235-112 Duckbill valve Vernay Laboratories, Inc $0 (free sample) 
VL 614-112 Duckbill valve Vernay Laboratories, Inc $0 (free sample) 
1CX*AF125X Capiox Arterial Line 




$0 (free sample) 
8486K353 Clear Cast Acrylic Tube 
2-1/2” OD x 2-1/4” ID 
McMaster-Carr $17.96 
8528K41 Clear Cast Acrylic Rod 
2-1/2” Diameter 
McMaster-Carr $33.07 
109 2-1/4” OD Silicone O-
Ring  
Carpenter Brothers $0.49 
97155A413 3/16” OD Dowel Pin McMaster-Carr $3.11 




N/A 3/8” ID Polyurethane 
Tubing, 3’ length 
Carpenter Brothers $2.25 
9227T412 Aluminum Woven Wire McMaster-Carr $7.44 
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Cloth, 20 X 20 Mesh, 
.016" Wire Diameter 
  Total $77.27 
 
21.2 Description of Engineering Changes since Design Review #3 
There have been several minor design changes since DR3, which came about primarily in the 
prototyping process due to availability of materials. These are listed below. 
• Dimensions and material of the dowel pins 
o New diameter: 3/16” (old diameter was 1/8”) 
o New material: stainless steel (old material was plastic) 
o New length: ½” (old length was ¼”) 
• Removal of the duckbill valve in the blood bag connector 
o The glue holding this valve in place failed during testing. Our solution was to 
purchase a three foot length of tubing and attach it with a hose clamp to the end of 
the blood bag connector. This tubing had to be manually plugged during testing 
but allowed us to complete validation testing. 
21.3 Materials Selection Assignments 
21.3.1 Functional Performance 
21.3.1.1 Syringe Housing 
 




Design requirement for the housing 
 
Function: Act as a reservoir for the fluid coming into the device and allow the plunger to 
pass through 
Objective: Minimize the mass 
Constraints: a) Length L specified 
  b) Cost < $5/lb 
  c) Density < 0.0358 lb/in3 
  d) Only thermoplastics for injection molding 
  e) Vickers Hardness > 7 HV 
 
Top 5 Material Choices as identified by CES: 
1) PE-HD (general purpose, molding) 
2) PE-UHMW (molding and extrusion) 
3) PMP (general purpose) 
4) PP (homopolymer, 10% mica) 
5) PP (homopolymer, 10% glass fiber) 
 
Out of these top 5 material choices, we choose Polypropylene (homopolymer, 10% mica).  This 
material is commonly used in medical components and can be injection molded, which is likely 
the manufacturing process that will be used for this device.  Furthermore, the Young’s modulus 
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is between 0.262-0.279 x 106 psi so this material can withstand the pressure loading on the 
housing from the external hand force.  The Vickers hardness of the material is also above the 
specified value of 10.2 HV. 
21.3.1.2 Plunger 
 
Material Index 𝑀 =  √𝐸
𝜌
 
Design requirement for the Plunger 
 
Function: Used as a piston for volume expansion and contraction to create a vacuum that 
will draw fluid into and out of the syringe. 
Objective: Minimize the mass 
Constraints: a) Length L specified 
  b) Cost < $5/lb 
  c) Density < 0.0385 lb/in3 
  d) Only thermoplastics for injection molding 
  e) Vickers Hardness > 7 HV 
 
Top 5 Material Choices as identified by CES: 
1) PP (homopolymer, 20% glass fiber) 
2) PMP (10-30% glass fiber) 
3) COC (general purpose) 
4) ABS (Injection Molding, Platable) 
5) PP (homopolymer, 10% mica) 
Out of these top 5 material choices, we choose COC (general purpose) which is commonly used 
in medical devices and is inert with blood.  The COC can be obtained in pellet form which 
makes this material ideal for injection molding.  This material has a high tensile strength of 9.09 
ksi so it can withstand the tensile strength being applied to the material when the plunger is 
pulled upwards.  The material also has a compressive strength of 10.9 ksi so it can withstand the 
compressive forces being applied to the material when the plunger is pushed downwards.  The 
Vickers hardness is between 8.36 – 9.35 HV which is above the constraint limit.   
 
21.3.2 Environmental Performance 
In our final design, we will require a mass of 0.5 kg of polypropylene and 0.5 kg of PMMA.  
These are the mass values that were used in our environmental performance calculations. 
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The PMMA (equivalent to the COC polymer) has a bigger impact on the environment within all 
four of the EI99 damage classifications.  This material also has the highest EI99 point value and 
is likely to have a bigger impact when the life cycle of the whole product is considered.  The 
main resource that is used in substantial quantities during the manufacturing of PMMA is water.   
The lifecycle of this device in use would be at most 1 procedure as a disposable medical device. 
Therefore, the impacts of the PMMA polymer in the device lifecycle would have a substantially 
greater impact than the COC polymer.  However, these two plastics fit within the environmental 
impact range of all plastics.  Therefore, we would not need to select a different material based on 
this analysis.  Furthermore, these are two plastics that are biocompatible with blood that is 
present in our device.  
21.3.3 Manufacturing Process Selection 
We have determined the real-world production volume for our project to be 100,000 units per 
year based on the incidence of ruptured ectopic pregnancies in the developing world.   
The manufacturing process that we have selected for the production of our housing 
(Polypropylene) and Plunger (COC) is injection molding.  Injection molding is a quick 
manufacturing process that can yield the 100,000 units per year needed to meet demand.  It can 
meet a production rate of 60 to 3000 units per hour.  Although the capital cost is high initially 
(~$500K), we can expect to distribute this cost amongst the large volume of units distributed.  
Injection molding is also an ideal process considering the tight manufacturing tolerances that we 
need in the barrel of the syringe.  To create the seal necessary with the o-ring, the inside diameter 
in the barrel must be consistent.  Therefore, extrusion processes will not work to create 
tolerances needed.  Both parts (housing and plunger) are symmetrical around one axis and can be 
easily injection molded.   
21.4 Functional Decomposition 
Coarse filter to 
remove blood clots









Transport blood to 
body
Connect to blood 
bag or IV
















Visual determination by doctor
Information about transfusion rate







21.5.1 Brainstorming Overview 
Concept generation was conducted in multiple phases, consisting of both systems-level and 
individual component-level brainstorming sessions. 
 
 
21.5.2 Component-Level Concepts Brainstorming 
We conducted multiple brainstorming sessions for individual components based on the 
functional decomposition of the device. The images below show the results of the primary 




















Transport to container concepts: 
 
 




21.5.3 Systems-Level Concepts Brainstorming 
Additional brainstorming sessions focused on systems-level concepts, in which we attempted to 
create an entire system which would accomplish all of the functional tasks without breaking up 






21.6 Pugh Chart 
The Pugh chart was developed as a method for comparing the many concepts that resulted from 
our brainstorming sessions. The chart was broken down into eight functional components which 
were compared on a weighted scale based on the rank of the user requirements and their 
relevance to each component.  











Sifter Clot Sword 
Removes clots, microaggregates 0.93 -1 0 -1 0 0 
Does not cause cell damage 0.86 0 0 -1 0 -1 
Closed system 0.83 -1 0 -1 -1 -1 
Sterilizable 0.8 0 0 1 0 0 
Manage significant blood loss 0.73 -1 0 -1 -1 -1 
Low maintenance 0.69 0 0 -1 0 0 
Durable 0.68 0 0 0 0 0 
Easy to operate 0.67 -1 0 -1 -1 0 
Low cost 0.65 1 0 -1 1 0 
Quick to operate 0.5 -1 0 0 -1 -1 
Quiet 0.43 0 0 0 1 0 
Weighted Sum  -3.01 0 -4.56 -1.65 -2.92 





We chose the Screen on Device/Wand.  Propose to add elements of "Clot Sword" to the 
Device/Wand. 
21.6.2 Insert device into body cavity 
Design Criteria 
Weighting 
Factor Hands-free clip 
Wand that 
















microaggregates 0.93 -1 1 -1 -1 0 1 0 
Does not cause cell damage 0.86 0 0 0 -1 0 0 0 
Closed system 0.83 0 0 -1 1 0 1 1 
Sterilizable 0.8 0 0 0 1 0 0 1 
Manage significant blood 
loss 0.73 -1 0 -1 1 0 0 0 
Sufficient flow rate 0.73 0 0 -1 1 0 1 0 
Measures blood collected 0.72 0 0 0 0 0 0 1 
Low maintenance 0.69 -1 -1 0 -1 0 -1 -1 
Durable 0.68 -1 0 0 -1 0 0 0 
Easy to operate 0.67 1 1 -1 0 0 1 -1 
Low cost 0.65 -1 -1 0 -1 0 -1 0 
Quick to operate 0.5 0 0 -1 -1 0 0 -1 
Quiet 0.43 0 0 0 0 0 0 1 
Weighted Sum  -3.01 0.26 -4.39 -1.22 0 1.82 0.92 
Comments 
The dual chamber tube came out on top in our weighted ranking, but we must consider the feasibility of 
this approach. The wand came in second. 
 












filters clots Resevoir 
Removes clots, 
microaggregates 0.93 0 0 0 0 0 1 0 
Does not cause cell damage 0.86 1 1 0 0 1 1 1 
Closed system 0.83 0 -1 0 0 0 0 0 
Sterilizable 0.8 0 -1 0 -1 -1 0 0 
Manage significant blood 




Sufficient flow rate 0.73 -1 -1 0 -1 -1 -1 -1 
Measures blood collected 0.72 0 1 0 0 0 0 1 
Low maintenance 0.69 1 0 0 -1 -1 0 -1 
Durable 0.68 1 0 0 -1 -1 0 0 
Easy to operate 0.67 -1 -1 0 -1 -1 0 0 
Low cost 0.65 1 1 0 -1 -1 0 -1 
Quick to operate 0.5 -1 -1 0 0 0 0 -1 
Quiet 0.43 1 1 0 0 0 0 1 
Weighted Sum  0.68 -1.6 0 -4.95 -4.09 1.06 -1.29 
Comments 
The scoop with suction that filters clots came out on top, but we would still like to evaluate the use of a 
siphon. 
21.6.4 Transport to container 
Design Criteria 
Weighting 
Factor Suction through tube Gravity Resevoir Siphon 
Does not cause cell damage 0.86 0 1 1 1 
Closed system 0.83 0 0 0 -1 
Sterilizable 0.8 0 0 0 0 
Manage significant blood loss 0.73 0 -1 -1 -1 
Sufficient flow rate 0.73 0 -1 0 -1 
Low maintenance 0.69 0 1 -1 1 
Durable 0.68 0 1 0 1 
Easy to operate 0.67 0 0 0 -1 
Low cost 0.65 0 1 1 1 
Quick to operate 0.5 0 -1 0 -1 
Quiet 0.43 0 1 1 1 
Weighted Sum  0 1.35 0.52 -0.15 
Comments: 



















driven Multiple filters 
Removes clots, 
microaggregates 0.93 0 1 1 1 0 1 
Does not cause cell damage 0.86 0 -1 -1 0 -1 0 
Closed system 0.83 0 0 0 0 0 0 
Sterilizable 0.8 0 0 -1 0 -1 0 
Manage significant blood loss 0.73 0 0 1 0 1 -1 
Sufficient flow rate 0.73 0 0 1 0 1 0 
Low maintenance 0.69 0 -1 -1 -1 -1 -1 
Durable 0.68 0 0 0 0 -1 0 
Easy to operate 0.67 0 0 0 0 0 0 
Low cost 0.65 0 -1 -1 -1 -1 -1 
Quick to operate 0.5 0 1 1 0 1 0 
Quiet 0.43 0 0 0 0 0 0 
Weighted Sum  0 -0.77 -0.11 -0.41 -1.72 -1.14 
Comments 
Gravity based filtering system comes out on top followed by Salad Spinner.  Evaluate Salad Spinner 
and funnel more. 
 




AC bag attached 










Add AC to 
reservoir 
Does not cause cell damage 0.86 0 0 0 0 0 0 
Closed system 0.83 0 0 0 0 0 0 
Low maintenance 0.69 -1 -1 0 0 -1 1 
Easy to operate 0.67 1 1 1 0 1 1 
Low cost 0.65 1 0 -1 0 -1 1 
Compatible with transfusion 
kit 0.64 0 0 0 0 0 0 
Quick to operate 0.5 1 1 1 0 1 0 




AC added to the resevoir comes out on top.  We still want to evaluate the silicone coating and its use 
in conjunction with another method.  Think about location and timing of adding the AC. 
 
21.6.7 Transport to body 
Design Criteria Weighting Factor Blood bag Reservoir Pump driven 
Closed system 0.83 0 0 0 
Sterilizable 0.8 0 0 0 
Prevents air embolisms 0.76 0 0 -1 
Manage significant blood loss 0.73 0 1 1 
Sufficient flow rate 0.73 0 1 1 
Measures blood collected 0.72 0 0 -1 
Low maintenance 0.69 0 1 -1 
Durable 0.68 0 1 0 
Easy to operate 0.67 0 0 -1 
Low cost 0.65 0 1 -1 
Compatible with transfusion kit 0.64 0 0 -1 
Quick to operate 0.5 0 1 1 
Controls transfusion rate 0.44 0 0 0 
Quiet 0.43 0 0 -1 
Weighted Sum  0 3.98 -2.6 
Comments 
Resevoir comes out on top.  We could consider having the resevoir as a back-
up to the blood bag in the event of overflow. 
21.6.8 Suction methods 
Design Criteria Weighting Factor Gravity  Pump Temp. change Piston Syringe 
Does not cause cell damage 0.86 0 0 -1 -1 0 
Closed system 0.83 0 0 0 0 0 
Manage significant blood loss 0.73 -1 0 -1 0 -1 
Sufficient flow rate 0.73 -1 0 0 0 -1 
Low maintenance 0.69 1 0 -1 0 0 
Durable 0.68 1 0 0 0 -1 
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Easy to operate 0.67 0 0 -1 0 -1 
Low cost 0.65 1 0 0 0 1 
Electrical power 0.52 -1 0 0 0 0 
Quick to operate 0.5 -1 0 0 0 -1 
Quiet 0.43 1 0 0 0 1 
Weighted Sum  -0.03 0 -2.95 -0.86 -2.23 
 
21.7 Pro/Con Lists of Top Concepts 
Salad Spinner 
Pro Con 
Better flow rate Standard filter size 
Larger surface area Maintenance of many parts 
Expansion to other surgeries Expensive 
No manual power Tolerance 
Large amounts of blood More possible opening s for contamination 
Modular Durability of Pump 
 
Dual -Action Pump 
Pro Con 
Modular High Maintenance 
Handle Large Volumes Lots of parts 
Generate High Flow Rate Expensive/manufacturing 
Control Each Component with valves  




Electrical/gravity Lots of parts 




Portable Small Scale 
Doesn’t require External Energy Air Embolisms 
Wide Scope Must be fully submerged 
 Need flexible material/not autoclaveable 




Self Contained Heavy to hold when filled with blood 
Low mintenance/ Less removable parts Force to pull plunger 
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Autoclavable May require more than one person 
Small/portable/durable Manufacturing Tolerance 
Doesn’t require pump Potential smaller SA on filter 
Scope of location Speed of removal 
Cost  
 
21.8 Alpha Design CAD Model 
 
 
21.9 Beta Design CAD Model 
 
 
Figure 30: Needle Tip and Filter 
 


































































21.10.5Blood Bag Connection 
 
 
21.11 Fluid Analysis MATLAB Code 
21.11.1Bernoulli Analysis 
 
% Bernoulli Analysis 
  
d = 1060; % density of blood (kg/m^3) 
g = 9.81; % gravity (m/s^2) 
  
% ------------------------ Barrel ------------------------------------ 
l2=linspace(0.08,0.27); %height of barrel 
v2=linspace(0,0.5); %possible velocities 
  
for i=1:length(l2) 
    for j=1:length(v2) 
        p2(i,j)= -0.00750061683*(-0.5*(d*(v2(j)^2))-(d*g*l2(i))); % mm Hg 




xlabel('Height of Barrel (m)') 
ylabel('Fluid velocity in Barrel (m/s)') 
zlabel('Pressure in Barrel (mmHg)') 
title('Pressure Array in Barrel') 
  
%--------------- Suction Tube ------------------------------------------- 
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% Point in reservoir to top of suction tube: 
% l1 = heights of suction tube 






    for j=1:length(v1) 
        p1(i,j)= -0.00750061683*(-0.5*(d*(v1(j)^2))-(d*g*l1(i))); % mm Hg 




xlabel('Height of Suction Tube (m)') 
ylabel('Fluid velocity in Suction Tube(m/s)') 
zlabel('Pressure in Suction Tube (Pa)') 
title('Pressure Array in Suction Tube') 
    




    for j=1:length(v2) 
        p3(i,j) = -0.00750061683*( p2(i,j) + 0.5*d*((v2(j)^2)-(v3(i)^2))); %mmHg 




xlabel('Fluid Velocity in Barrel (m/s)') 
ylabel('Fluid velocity in IV Tube (m/s)') 
zlabel('Pressure in IV Tube (mmHg)') 
title('Pressure Array in IV Tube') 
  
p21 = linspace(0,6000); 
p31 = 0.00750061683*(p21+(0.5*d*((v2.^2)-1.49))); %mmHg 
plot(v2,p31) 
xlabel('Velocity in Barrel (m/s)') 
ylabel('Pressure in IV Tubing (mmHg)') 
title('Pressure in IV Tubing') 
 
 
21.11.2Force on Plunger Analysis 
 
%----------  Force Analysis --------------------------------------- 














         
%----------- First Phase ------------------------------------------------ 
t=linspace(0,5); 
  
V1 = sqrt(((((2*F)/(density*pi*(r21^2))).*log(t))+ ... 
     (4.605*F/(density*pi*(r21.^2))))); 
  
V2 = sqrt(((((2*F)/(density*pi*(r22^2))).*log(t))+ ... 
     (4.605*F/(density*pi*(r22.^2))))); 
  
V3 = sqrt(((((2*F)/(density*pi*(r23^2))).*log(t))+ ... 




ylabel('Velocity of Plunger (m/s)') 











ylabel('Velocity of Plunger (m/s)') 








ylabel('Velocity of Plunger (m/s)') 









ylabel('Velocity of Plunger (m/s)') 




21.11.3Design Dimension Analysis 
 










%--------- Barrel Pressure ----------------------------------------- 
v2=linspace(0,0.5); 
p2 = -0.00750061683*((-0.5*d*(v2.^2))-(d*g*h2)); 
  
plot(v2,p2) 
xlabel('Velocity in Barrel') 
ylabel('Pressure in Barrel (mmHg)') 
title('Pressures in  Barrel') 
  
%--------- Suction Tip Pressure ----------------------------------------- 
a1 = pi*(r1^2); 




p1 = -0.0075006168*(-0.5*d*(v1.^2)-(d*g*h1)); 
  
plot(v1,p1) 
xlabel('Velocity in Suction Tip') 
ylabel('Pressure in Suction Tip (mmHg)') 
title('Pressures in  Suction Tip') 
 




   
p3 = -0.0075006168*(p21+0.5*d*((v2.^2)-(v3.^2))); 
  
plot(v3,p3) 
xlabel('Velocity in IV Tubing') 
ylabel('Pressure in IV Tubing(mmHg)') 















Auto Blood Transfusion Device 
To be used in: Ectopic Pregnancy Ruptures, Myomectomies, Hysterectomies, and other clean abdominal surgeries 
(hemoperitoneum)   
Need statement: There is a need for a blood salvage device that can be operated y a healthcare provider to collect, 
filter, and transfuse blood in the event of life-threatening blood loss, which would address the lack of donated blood 
and improve the prognosis for the patient. 
Stakeholders User Requirement Ranking Survey 
Name: ___________________________  Phone Number: _____________________________  
Email Address: ____________________  Occupation/position: _________________________ 
Please circle one number for each requirement and circle your top 5 requirements and cross-out your 5 least 
important 
1 = Very important (a critical requirement; required for operation) 
3 = Important (required eventually but could wait until a later release if necessary) 
9 = Somewhat important (would be nice to have someday if resources permit) 




Removes particulates and blood clots 1 3 9 
Minimizes contamination from environment 1 3 9 
Main power source is electrical 1 3 9 
Backup power source is mechanical 1 3 9 
Quick transition to backup power 1 3 9 
Connects to existing blood transfusion kit 1 3 9 
Can be used in any clean abdominal surgery 1 3 9 
Minimizes risk of cross contamination between patients  1 3 9 
Easy to operate by any staff in surgical setting 1 3 9 
Device can be operated quickly 1 3 9 
Device is low cost 1 3 9 
Device is low maintenance 1 3 9 
Device is small 1 3 9 
Device is portable 1 3 9 
Alerts user when malfunctioning 1 3 9 
Can contain large amounts of blood loss 1 3 9 
Can change transfusion rate 1 3 9 
Prevents air embolisms 1 3 9 
Device is quiet 1 3 9 
Measures amount of blood lost by patient 1 3 9 
Measures amount transfused to patient 1 3 9 
Durable and is long lasting 1 3 9 
Do you have any additional user requirements? How would you rank them? 
96 
 
21.14 Additional Activities 
Our team has been involved in a number of additional activities in conjunction with our primary 
objective of the technical development of the blood salvage device. These are listed briefly 
below. 
• Dhani Jones presentation, October 15, sponsored by the Center for Entrepreneurship to 
highlight social entrepreneurship ventures on campus. 
• Chicago Entrepreneurial Experience, October 18-19, sponsored by the Center for 
Entrepreneurship to bring local student companies to Chicago, including a pitch 
competition and networking session with successful UM Alumni-Entrepreneurs. Our 
team took third place in the pitch competition 
• Global Health Day Poster Presentation, November 5, sponsored by the Center for Global 
Health 
• Ann Arbor SPARK Entrepreneur Boot Camp, November 4-5 
